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Abstract 
Long-term potentiation of a synaptic and/or spike response, which is widely 
accepted as a model for neuronal plasticity, was initially elicited by high frequency 
stimulation in the hippocampus (Bliss and Lomo, 1973), but can also be induced by 
neuromodulators like norepinephrine (NE; Neuman and Harley, 1983; Walling and 
Harley, 2004). The neuropeptide vasopre sin (A VP) (Chen et al, 1993; Chepkova et al , 
2001 ; Dubrovsky et al , 2002; Dubrovsky et al , 2003) also produces enhancement of 
synaptic responses and has a role in promoting memory (Bohus et al, 1982). In vitro 
studies have shown NE plays a role in AVP-initiated increases in cyclic AMP (cAMP) 
(Brinton, 2000; Brinton, 1993). 
It has been proposed that NE, released into the dentate gyrus in vivo mediates 
A VP memory enhancement (Bohus et al , 1993 ). This thesis examined 1) the perforant 
path-dentate gyrus evoked response after intracerebroventricular (icv) A VP; 2) the ~­
adrenergic influence on perforant path A VP effects through the use of a double pipette 
procedure using the ~-adrenergic antagonist, propranolol; and 3) further exan1ined the 
pharmacology of the perforant path A VP response by the use of the V 1 a selective agonist 
DGA VP, an AVP fragment without peripheral effects, in the urethane anesthetized rat. 
In the first experiment, A VP (1 ng; icv) produced potentiation of perforant path 
population spike amplitude in 15/ 16 animals and of the EPSP slope in 11/16 animals. 
AVP significantly increased the population spike amplitude with a mean increase of 50% 
over baseline at 30 minutes after A VP. Individual animals showed increases of up to 
100% at peak potentiation. The mean increase for EPSP slope was 21 % over baseline at 
30 minutes after AVP. Those experiments followed beyond an hour (n=4) showed mean 
amplitude increases of 100% at 60 minutes and mean slope increases of 24% at 60 
minutes. At 100 minutes post A VP, mean spike amplitude was at a 90% increase with the 
EPSP slope at a 16% increase above baseline. 
In the second experiment using a two-pipette recording technique, perforant path 
evoked potentials were recorded using a ~-adrenergic antagonist (propranolol)-filled 
pipette and a saline-filled pipette before and after icv A VP. A VP produced a mean 
increase of 50% of the baseline population spike amplitude in all 6 animals on the saline 
pipette at 30 minutes after A VP. A VP also produced potentiation of the EPSP slope on 
the saline pipette in all animals with a mean increase of 25% at 30 minutes after A VP 
infusion. With the propranolol pipette at 30 minutes all 6 animals showed an unchanged 
or decreased population spike amplitude averaging 21% of baseline and a decreased 
EPSP slope averaging 26% of baseline. 
In the final experiment, the A VP fragment, DGA VP increased in the population 
spike amplitude in 3 animals with a mean amplitude of 100% above baseline at 30 
minutes which remained constant at 60 minutes. DGA VP did not significantly alter EPSP 
slope. 
Taken together, the results of these experiments demonstrate that A VP produces 
long-lasting potentiation of the perforant path evoked potential in vivo in the dentate 
gyrus, without tetanic stimulation. This confirms in vitro experiments on the effects of 
A VP on the perforant path evoked potential. The dependence of A VP-induced 
electrophysiological potentiation on NE receptor mediation in the dentate gyrus parallels 
the results obtained with A VP-infusion in the dentate gyrus in vivo on the potentiation of 
avoidance memory and with in vitro effects of A VP potentiation of NE-mediated cAMP 
production. 
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Introduction 
Learning and memory are essential for all animals in order to satisfy their own 
basic needs and to adapt to changes in the conditions of life. For every li ving organism, 
adaptation reflects behavioral modification by experience. In order to cope with these 
ongoing challenges throughout life, the brain is constantly recon tructing it e lf. Thus the 
cognitive, behavioural and emotional tatus of an organism reflects a li fe long self-
adjustment and self-optimization process . Ne uronal plasticity is a fundam ntal process by 
which the brain adapts to sensory, cognitive, emotional, social, and endocrine inputs or a 
combination of such inputs . During learning and memory, neurotransmitters and 
neuropeptides promote a variety of structural and molecular changes that take place 
throughout the brain . 
Ramon Y Cajal initial ly proposed a theory of memory storage as involving the 
growth of new connections or the alteration of existing ones (Bailey et al. , 2000). Donald 
Hebb further proposed that memories are represented as enduring changes in the 
functional circuitry of the brain and that the synaptic contacts between neurons serve as 
the pliable ub trate for " memory traces" (Abraham et al., 1991 ). Specifically Hebb 
suggested the association of pre- and post- synaptic activity in two neurons elicits some 
change in one or both of the neurons such that the synaptic connection between them i 
stre ngthened (Hebb 1949) . This model for memory formation has been inten ively 
studied in the dentate gyrus of the hippocampus, a structure which initially provided 
evide nce of long-la ting synaptic plasticity in the mammalian brain (B ii and Lomo 
1973). The di scovery of long-lastin g potentiated synaptic responses supported Hebb' s 
hypothesis of a cellular mechanism for learning and memory. 
Long-term potentiation (LTP) of a synaptic response, which is widely accepted 
as a mode l for neuronal plasticity was initially e lic ited by hi gh frequency sti mulat ion 
(Bliss and Lomo, 1973), but a! o can be induced by a neuromodulator li ke 
norepinephrine (NE ; Neuman and Harley , 1983 ; W alling and Harley, 2004). The 
neuropeptide argtntne vasopresstn (A VP) (Chen et al, 1993; Chepkova et al, 200 I; 
Dubrovsky et al, 2003) a lso produces enhancement of synaptic responses suggesting its 
possible role in memory formation . Studies have examined whether A VP and NE 
together play a neuromodulatory role in synaptic plasticity (Brinton, 2000; Brinton, 
1993). 
The present study is concerned with two hypothe e . The first is that in vtvo 
A VP will induce long lasting potentiation of perforant path input to the dentate gyrus, as 
has been observed in vitro (Chen et a l, 1993), without tetanic stimulation of the perforant 
path. The second is that the modulation of the perforant path potential by A VP is 
dependent upon ~-adrenoceptor activation. 
These hypotheses arise from earlier evidence that A VP effects on learning and 
memory in the dentate gyrus require NE input to be effective (Bohus et al, 1993; Kovacs 
et al, 1979a; J 979b). If NE mediates the effects of AVP on learning and memory, and, if 
long-term potentiation-like effects play a critical role in learning and memory, AVP 
should, through its interactions with NE, produce an A VP-LTP of perforant path input 
that requires ~-adrenoceptor support as doe the LTP effect of NE itself. Finally, the 
abi lity of a more restricted Vl activating fragment to induce perforant path LTP is 
assessed. 
The introduction briefly reviews A VP pathways and receptor distribution, reviews 
evidence of the role that AVP may play in learning and memory and the evidence for 
memory-like changes in the dentate gyrus circuit with an emphasi on tho e mediated by 
NE and A VP. The focus first turns to the structure mo t studied in memory research, the 
hippocampus and, more specif icall y, the dentate gyru . 
1.1 The Hippocampal Dentate Gyrus and Memory Processes 
2 
The hippocampus is a bilaterally symmetrical structure comprised of the 
hippocampus proper and the dentate gyrus. These two fields each contain a dense ly 
packed sheet of cells, pyramidal and granule cells respectively, which are the principal 
cell type of their field and which project outside their respective fields, as well as a 
variety of interneurons, cells which limit their influence to the local circuit (Teyler, 
1991 ). An important feature is the intrinsic trisynaptic circuitry of the hippocampus: the 
entorhinal cortex projects to dentate gyrus granule cells (the perforant path), the granule 
cells project onto CA3 pyramidal cells (the mossy fiber system) which project to CA 1 
pyramidal cells (the Shaffer collaterals) which in turn project to the subiculum. The main 
input into the hippocampal system is from the entorhinal cortex which receives inputs 
from multiple cortical regions and all sensory modalities. One of the primary projections 
of the entorhinal cortex is to the dentate gyrus via cells in its second cortical layer 
(Amaral and Witter, 1995). Thus the granule cells are in a position to control the flow of 
information within the hippocampus as they receive excitatory input from the entorhinal 
cortex via the perforant path into the molecular layer, and activate pyramidal cells in CA4 
and CA3. 
The hippocampal formation has been one of the most extensively studied regions 
in the quest for further understanding of learning and memory processes. Much of the 
evidence used to examine the hippocampus and its role in learning and memory was 
obtained through experimental studies with animals where damage was not limited to the 
hippocampus. Selective removal of the hippocampal region consisting of CA I-CA3 
pyramidal cells and hilar and granule cells in the dentate gyrus gives a clearer picture of 
the extent of hippocampal involvement in learning and memory. In studies by Jarrard and 
colleagues (Bouffard and Jarrard, 1988; Morri s et al, 1990), axon-sparing ibotenic ac id 
le ions of the hippocampus are used to study the effects of selective removal on the 
acquisition of spatial and non-spatial information; complex, non-spatial representational 
learning; and acquisition and utilization of contextual information. These studies show 
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that rats with selective hippocampal removal by ibotenate lesioning exhibit severe 
impairments in acquisition of spatial information when tested in the radial maze 
(Bouffard and Jarrard, 1988), the rewarded alternation task (Jarrard and Hyko, 1994) and 
the Morris water maze (Morris eta!. , 1990). In general, these studies have shown that the 
performance of the rats with the hippocampus removed is impaired on tasks that require 
utilization of spatial and contextual information, but is like that of controls in the learning 
and handling of non-spatial information. 
Many studies have tried to exan1ine the specific function of the dentate gyrus and 
its role in learning and memory. These studies have found that intradentate colchicine, a 
neurotoxin that preferentially destroys granule cells and mossy fibers, disrupts the 
acquisition and performance of spatial reference memory in the Morris swim maze 
(Sutherland eta!, 1983; Jeltsch eta! , 2001), working memory in the radial arm maze 
(McLamb et al, 1988a; Jeltsch et a! , 200 I) and the acquisition of a two-way active 
avoidance response in a Y-maze (McLamb eta!, 1988b). Xavier and colleagues (1999) 
tested rats with dentate gyrus lesions on tasks requiring spatial reference and working 
memory in the Morris water maze and found that their deficit was the san1e as rats with 
complete hippocampal lesions when the start location varied on each trial. From their 
findings, Jeltsch and colleagues (2001) speculated that both types of memory are 
sensitive to granule cell damage. 
Rolls (1996) suggests that pattern separation may be a function of the dentate 
gyrus and the mossy fiber projections to CA3. Pattern separation can be described as a 
mechanism for separating partially overlapping patterns of activation so that one pattern 
may be retrieved as separate from the other pattern (Rolls 1996). Rolls' model proposes 
that pattern separation is facilitated by the sparse connections in the mossy fiber system, 
which connects granule cells in the dentate gyrus to pyran1idal neurons in the CA3. The 
mossy fiber inputs to the CA3 from the dentate gyrus may influence which CA3 neurons 
will fire based on the distribution of activity in the dentate gyrus. 
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Lee and Kesner (2004) tested rats with selective dentate gyrus lesions on the 
acquisition and retrieval of contextual fear conditioning. The lesioned rats showed initial 
impairments in freezing behavior but eventually reached the level of freezing in controls 
with subsequent training. When retrieval was examined in rats with dentate gyrus lesions 
24 hours after acquisition, the animals showed a significant deficit in freezing compared 
to controls. These studies support the hypothesis that the dentate gyrus plays a role in 
both the encoding and retrieval of spatial information. 
Since the dentate gyrus receives inputs from all sensory modalities, it is possible 
that the dentate gyrus uses sensory markers to mark a spatial location. Kesner and 
colleagues (2004) speculate that one function of the dentate gyrus would be to encode 
events and separate events in space resulting in spatial pattern separation. This would 
ensure that new highly processed sensory information is organized efficiently in the 
hippocampus. The induction and maintenance of LTP in the dentate gyrus is enhanced 
after exposure to novel or enriched environments (Davis et a l, 2004) suggesting a role in 
encoding new spatial environments. 
1.1.1 Long-term Potentiation 
In 1949, Donald Hebb published his now famous synaptic modification postulate : 
"When an axon of cell A is near enough to excite cell B and repeatedly or persistentl y 
takes part in firing it, some growth process or metabolic change takes place in one or both 
cells such that A 's efficiency, a one of the cells firing B, is increased" (Hebb, 1949). 
In 1973, Bliss and Lomo first reported that brief high-frequency electrical 
stimulation of the perforant path input to the dentate gyrus of the hippocampus could 
elicit a Ia ting enhancement of synaptic transmission in thi pathway that persisted for 
days and this enhancement was termed LTP. LTP is a synapse-specific enhancement of 
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excitatory postsynaptic responses that has been repeatedly proposed as a mechanism of 
memory (Douglas & Goddard, 1975; Bliss & Collingridge, 1993; Izquierdo, 1993). LTP 
shares several characteristics with memory including synapse specificity (Dunwiddie and 
Lynch, 1978), rapid acquisition, incremental nature, durability and persistence for very 
long periods in the absence of stimulation. The fact that it can be triggered by brief trains 
of high frequency stimulation is presumably analogous to the way brief, unique sensory 
or behavioral stimuli set the learning process in motion (Teyler and DiScenna, 1987; 
Bliss & Collingridge, 1993; lzquirdo & Medina, 1995). In addition, LTP is accompanied 
by biochemical and morphological changes which have long been proposed as a basic 
mechanism upon which synaptic connections are strengthened as a result of a learning 
expenence. 
Andersen and Lomo ( 1966) electrophysiologically examined the unique anatomy 
of the hippocampus and found that the extracellular population field potentials recorded 
at various depths directly reflect excitatory postsynaptic potentials (EPSPs) and cell body 
spike discharges. The evoked potentials reflect summed synaptic currents (EPSP) and 
unit spiking activity (population spike). The response of the population of granule cells 
firing action potentials to elicited perforant path stimulation is measured as the population 
spike. The initial slope of the evoked response is a measure of synaptic strength. Long-
term potentiation, L TP, was first described in the dentate gyrus and was seen as long-
lasting increases in both the population spike amplitude and in EPSP slope (Bliss and 
Lomo, 1973). 
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1.1.1.1 Dentate and Long Term Potentiation (LTP) studies 
Bliss and Lomo (1973) set a precedent for studying field potentials in the dentate 
gyrus in awake animals for the purpose of investigating the properties and persistence of 
LTP. Briefhigh frequency stimulation of the dentate gyrus in the rabbit in vivo was found 
to induce LTP lasting as long as 3 days. Tetanization of the perforant path results in 
robust and enduring increases in the population spike amplitude and the EPSP slope in 
the dentate gyrus evoked by single pulse stimulation of this input pathway (Bliss and 
Lomo, 1973; Bliss and Garner-Medwin 1973; Bronzino et al.,1994). This homosynaptic 
LTP is presw11ed to involve glutamate-mediated modulation of glutan1ate synapses. 
However some early studies established that perforant path stimulation affected 
the population spike and EPSP components differently. Potentiation of the population 
spike was found to be much greater than that of EPSP (Bliss and Gardner-Medwin, 
1973). Racine and colleagues (1983) reported that the EPSP potentiation decayed at a 
faster rate than the population spike potentiation. Subsequent studies from several labs 
confirmed in rats that LTP can last from 1 hour to a day to many weeks, depending on the 
stimulation parameters (Barnes 1979; de Jonge and Racine 1985; Staubli and Lynch 
1987; Jeffrey et al., 1990; Abraham et al., 1993; Bronzino eta!, 1994). Abraham and 
colleagues demonstrated that in the dentate gyrus L TP could last many months ( 1993 ), 
even up to a year (Abraham et a!, 2002), tmder certain conditions. Protocol variables like 
the number and timing of high frequency stimulus trains (Huang and Kandel, 1994; 
Abraham et al 2002), the time before and after stimulation that the animal is in the 
recording chamber (Abraham et al 2002) and the level of neuromodulatory activity at the 
induction time (Swanson-Park et al 1999) have been found to influence L TP duration. 
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Studies have reported that the unusuall y long duration of LTP may be due to 
structural synaptic modifications such as an increase in the number of synapses (Lynch et 
al. , 1988; Lynch and Baudry, 199 1; Bliss and Collingridge, 1993) and change in 
dendritic spines. M any studies have reported that the earl y maintenance phase of LTP in 
the dentate gyrus is p rotein synthesis-dependent (Otani and Abraham , 1989; Otani et al. , 
1989; Nguyen e t al. , 1994). Ke lly et al ( 1998) reported that nerve growth factor plays a 
role in potentiation of the rat perforant path-granule cell synapses . 
1.1.1.2 Norepinephrine-Induced LTP 
The neurotransmitter NE has been studied in the hi ppocampus and been found to 
be in volved both in memory processes and in hippocampal plasticity. In behavioral 
studies, NE has been linked to e nhanced memory retrieval, increased behavioral 
responses to novel objects or novel s timulation, and facilitated learning of new response 
contingencies in a famili ar task (Sara and Bergis, 199 1 ). Various studies have shown that 
NE depletion in rode nts and monkeys results in increased distractabili ty and deficits in 
spatia l working memory while administration of NE agonists improved me mory 
perfo rmance (Carli et al, 1983; Arnsten and Contant, 1992; Cai et al, 1993 ). The major 
source of dentate gyrus NE is the terminals of the locus coeruleus (LC) (Loy et al, 1980) . 
The LC has been a s ite of acti vation fo r studies examining the physio logical effects of 
NE release (Dahl and Winson, 1985; Harley and Milway, 1986; Harley et al 1989; 
Klukowski and Harley, 1994; W alling et al, 2004) . The LC is a noradrenergic nucle us of 
the pontine reticul ar fo rmation , which sends a dense terminal projection to the dentate 
gyrus, as well a to neocortex and other fo rebrain areas (Aston-Jones et a l, 1999) . 
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Stimulation of this ascending NE pathway was initially reported to modulate the 
rate of spontaneous unit activity in the hippocampus (Segal & Bloom, 1976), and the 
spike potential amplitude evoked by stimulation of the main excitatory input to the 
dentate gyrus, the perforant path (Assaf et al, 1978). NE-modulated signals were first 
observed in the hippocampus by Segal and Bloom ( 1976). They reported that 
iontophoresed NE appeared to suppress all hippocampal unit firing whether spontaneous 
or driven by cholinergic stimulation, but natural release of NE through activation of the 
LC enhanced tone-induced excitation (Segal & Bloom, 1976). Also enhancement was 
observed when LC stimulation was paired with sensory inputs to neocortex (Berridge and 
Foote, 1991 ). These results led to the proposal that LC-NE acts to enhance the signa l-to-
noise ratio both in sensory areas and in the hippocampus (Harley, 1991 ). 
In 1983, NE application in the dentate gyrus was found to result in a long-lasting 
potentiation of the perforant path evoked population spike amplitude in the granule cells 
of the dentate gyrus. Neuman and Harley ( 1983) observed that one to e ight minutes of 
NE iontophoretic application in the granule cells produced a potentiation of the 
population spike amplitude that climbed to 40% in vivo and lasted at least 30 min. Such 
observations were reported as NE-induced long-lasting potentiation (NELLP), a 
heterosynaptic modulation by NE of glutamate responses to distinguish it from the tetanic 
stimulation-induced homosynaptic potentiation. 
1.1.1.3. Norepinephrine-Induced Long-Term Potentiation: In vitro studies 
Lacaille and Harley ( 1985) found that in the hippocampal slice, ten minute of NE 
exposure ( lO ~)produced a 31% enhancement of spike amplitude that was long-lasting 
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(30 minutes) in one-quarter of the experiments. Forty-seven percent of the spike 
ampl itude potentiation could be accounted for by the increase in EPSP slope, thus 
suggesting an additional increase in EPSP/spike coupling. The population spike and 
EPSP slope potentiation was seen in all s lices exposed to the ~-adrenoceptor agonist 
isoproterenol and was blocked with a ~-adrenoceptor antagonist, timolo l, arguing for ~­
adrenoceptor mediation. In contrast, an a-receptor agoni st, phe nylephrine, and 
antagonist, phento lamine produced only weak effects. 
Stanton and Sarvey ( 1985) carried out a number of in vitro experime nts to better 
examine NE effects in the dentate gyrus. They discovered two fo rms of NE-induced 
potentiation of population spike amplitude through the mani pul ation of emetine , a protein 
synthesis inhibitor. A short-te rm NE-induced potentiation was seen in the presence of 
emetine . This potentiation only lasted as long as NE was present. An NE-induced long-
lasting potenti ation occurred in the absence of emetine and lasted for the 5 hour recording 
time. The thirty minutes of NE superfusion produced an enhancement of spike amplitude 
that was 85% greater than control. In the same study, Stanton and Sarvey ( 1985) found 
forskolin, an adenylate cyclase activator, greatly enhanced the NE-potentiation dose-
response curve supporting a ro le for adenylate cyc lase generation of cAMP in NE 
potentiation. Both forms of NE potentiation were blocked by the ~-adrenergic antagon ist, 
propranolo l, a ~ 1 /~2 antagonist and metoprolol, a ~ 1 antagonist. 
In a subsequent study, Stanton and Sarvey ( 1985b) examined slices from normal 
and NE-depleted hippocampi and found high frequency LTP of the perforant path 
population spike was blocked in the dentate gyrus . Upon recovery from the depletion , 
LTP occurred in the s lice. Forsko lin and ~-adrenergic antagonists produced the same 
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results as in the pre vious study. The fin al follow-up study reported that LTP in the 
dentate gyrus and NELLP both corre lated with increased cAMP in the dentate gyrus, with 
NE stimulation showing increased cAMP long afte r washout (Stanton and Sarvey, 
l985c). These studies by Stanton and Sarvey supported the existence of NELLP in the 
dentate gyrus in vitro and showed that thi s fo rm of LTP depends on the activation of ~­
adrenergic recepto rs, adenylate cyclase and protein synthesis and the e levati on of cAMP. 
They also argued that high freque ncy LTP in dentate gyrus no rmally recruits this 
pathway. 
1.1.1.4 Norepinephrine-induced Long-Term Potentiation: in vivo Studies 
As discussed previously, Neuman and Harley ( 1983) first described NELLP in the 
dentate gyrus in vivo in anesthetized animals in which the population spike of the 
perforant path potential was consiste ntly potentiated by NE iontophoresis in the granule 
cell layer. A subsequent study conducted by Dahl and Winson ( 1985) in vivo supported 
thi s long-lasting enhancement of the population spike amplitude. In one of the earliest 
experiments on the modulation of perforant path evoked potential in the dentate gyrus by 
LC electrical stimulation , they reported that the population spike amplitude showed long-
lasting potentiation w ithout any change in the EPSP slope at the cell body level. They 
observed a decrease in the EPSP slope at the dendritic level. 
Population spike enhancement has also been found fo llowing glutamate activation 
of the LC to stimulate endogenous NE in the anaesthetized rat. Harley and Milway 
( 1986) ejected glutamate into the LC and reported a pike enhancement 40% greater than 
the controls and lasting more than 20 minutes in 39% of the animals tested. The EPSP 
lope increased briefl y (2-3 minutes) in half of the experiments and decreased or was 
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unchanged in the remainder of experiments. The different latencies suggested that EPSP 
slope and spike effects were uncorrelated. Another study by Harley and Evans ( 1988) 
supported these results. Harley and Sara ( 1992) found the EPSP s lope again did not 
corre late with the population spike amplitude. EPSP slope increases occurred on less than 
30% of the evoked po tentials with increased population spikes. 
Recentl y, W a lling and colleagues (2004) in vestigated the acti vation of the LC in 
the urethane anesthetized rat by the neuropeptide, orex in-A. They reported that orexin-A 
caused a long-lasting and graduall y increasing (over 3 hours) potenti ation of the 
population spike amplitude with no change in the EPSP slope . 
Spike amplitude enhancement by glutamate acti vation of the LC has also been 
seen in the awake animal (Sara and Bergis, 199 1; Klukowski and Harley, 1994; Walling 
and Harley, 2004). A study in the awake rat by Sara and Bergis ( 199 1) examined effects 
of the drug idazoxan, which increases the release of NE, and found potenti ation of the 
population spike amplitude, but no change in the EPSP slope . W alling and Harley (2004) 
studied NE release and subsequent modulation of the perforant path evoked potential in 
dentate gyrus at 3 hours and at 24 hours fo llowing glutamate acti vation of the LC. They 
found that LC activation resulted in immediate spike potentiation Ia ting 3 hours, but 
observed both spike and EPSP s lope potentiation 24 hours after LC activation. 
Propranolo l, a ~-adrenerg i c antagonist, and anisomycin , a prote in synthesis inhibitor, 
given (icv) before LC activation was found to block both slope and spike potenti ation at 
24 hours. Thus, LC activation seems to initi ate a ~-adrenergic and protein synthesis 
dependent long-lasting enhancement in the granule cell excitability and synaptic stre ngth 
of the perforant path input to the dentate gyrus. 
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While in vitro studies concluded that a-agonists failed to mimic the effects of NE 
and that a ll potentiation depended on ~-receptor activation, Chaulk and Harley ( 1998) in 
an in vivo study, found a possible role for both a- and ~-adrenoceptors in NE 
potentiation. They used icv NE to mimic in vitro conditions in. vivo and found that both 
the ~-agonist isoproterenol and the a-agonist phenylephrine, produced potentiation 
although potentiation was more commonly long-lasting in isoproterenol treated animals. 
Both ~-and a-antagonists attenuated NE potentiation in the icv studies. Babstock and 
Harley (1992) examined the role of the ~-receptors in. vivo after stimulation of the 
paragigantocellularis (PGI). The PGI provides a major source of glutamate excitation to 
the LC which is another method of activating NE release. PGI activation induced only 
spike potentiation which was blocked by the ~-antagonist propranolol. In contrast, Munro 
and colleagues (200 1) found that the ~-antagonist, timolol , partially prevented high-
frequency- induced LTP in. vivo of the EPSP slope, but LTP of the population spike 
amplitude was unaffected. 
The inconsistent demonstration of LTP of the EPSP slope in NE-induced 
potentiation studies in. vivo stands in contrast to the previous in. vitro data but is fairly 
consistent within the in vivo experiments. 
NE-induced LTP shares important qualities with the late-phase tetanic induced 
LTP. ~-adrenergic receptor activation was found to be required for tetanus-induced late-
phase LTP at both the lateral and medial perforant pathways (B ramham et al., 1997) and 
at the mossy fiber-CA3 synapse (Huang and Kandel , 1996). More recently, Straube et al. 
(2003) have shown that novelty exploration transforms earl y-phase LTP (non-protein 
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synthesis dependent) in the dentate gyrus into late-phase LTP, which is prevented by the 
~-antagonist propranolol, as well as by the protein translation inhibitor, anisomycin . 
NE has been reported to work with the neuropeptide A VP in the enhancement of 
memory (Kovacs et al, 1979a; 1979b) which will be discussed shortly. The following 
section is a brief overview of A VP, its anatomical distribution and its historical role in 
learning and memory studies. 
1.2AVP 
1.2.1 Structure, neural pathways and receptor distribution 
A VP is a nonapeptide derived from larger precursor proteins. In peptide synthesis, 
the am ino group of one amino acid is bonded with the carboxyl group of the adjoining 
amino acid. The side chains of the amino acids identify the various peptides and are 
responsible for their physical and functional attributes (McEwen 2004) . AVP and 
oxytocin are synthesized in , transported within, and secreted by both magnocellular cells 
and parvocellular cells which are predominantly located within the paraventricular (PVN) 
and supraoptic (SON) nuclei. The magnocellular cel ls are neuroendocrine cells which 
project to the capillaries in the posterior pituitary lobe where they secrete their contents as 
hormones into the systemic circulation. Some parvocellular cells secrete releasing 
hormones into the portal circulation of the anterior pituitary gland, others activate, 
inhibit, or modulate, activity in other neurons in the brain and others synapse on blood 
vessels in the brain (Sofroniew, 1985; Buijs et al, 1991 ). Extrahypothalamic (from the 
bed nucleus of the stria terminal is) and hypothalamic (from PVN) A VP-ergic fibers 
innervate limbic areas like septum and hippocampus (Sofroniew 1985; Buijs 1991 ). A VP 
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and OT are released synaptically from axon terminals and from dendrites and somata of 
hypothalamic neurons (Pow and Morris, 1989). 
The neuropeptide concept was originally formulated by De Wied ( 1965) when his 
findings indicated the neurogenic effects of pituitary hormones. Generally, De Wied 
came to recognize that A VP is a peptide that can act at both peripheral target sites and at 
neural structures within the brain. In both periphery and brain, metabolic alterations 
mediated by peptidase enzymes convert the parent peptide into smaller peptides. The 
neuropeptide concept proposes that in the brain the smaller active fragments generated 
from A VP can function as neurotransmitters or neuromodulators at brain target sites. It 
also suggests that some of these fragments act at relevant brain sites to influence memory 
consolidation and retrieval. Traditionally in De Wied' s studies lysine vasopressin (LVP) 
has the same function as A VP but the form is found only in the pig. A number of studies 
carried out by De Wied and colleagues (1972) found that the entire A VP molecule, which 
produced other hormonal effects, was not required for effects on memory processes. 
Desglycinamide-lysine vasopressin (DG-LVP), produced from the parent peptide LVP 
with the glycine residue removed, lost its endocrine activity but retained its ability to 
inhibit extinction of a pole-jump avoidance response. The behavioral research of De 
Wied and colleagues is reviewed in a later section. 
Studies have shown that A VP binding sites are widely distributed throughout the 
brain and the spinal cord (Tribollet et al., 1998). Tribollet and colleagues ( I 998) 
summarized the distribution of central A VP binding sites using micro copy 
autoradiography in the adult rat brain and compared it with distribution patterns found in 
other mammalian species. Receptors specific for A VP were identified within numerous 
areas of the brain and spinal cord in the rat and other mammals but there are marked 
IS 
------------------ - ----------------------
species related differences in their distribution, which may be because these receptors 
mediate species typical behaviors. 
Some studies using non-radioactive selective analogues together with tritiated 
AVP suggested that only V1a-like vasopressin receptors are detectable within the brain 
(Barberis eta!, 1995; Tribollet eta!. , 1998b). There appears also to be an absence of V2 
receptor mRNA in the adult rat brain (Ostrowski eta!, 1992; Saito eta!, 1995), whereas it 
may be expressed during development (Saito eta!, 1995; Croiset and De Wied, 1997). A 
study by Hirasawa and colleagues (1994) suggests that the hippocampus also contains 
V 1 b receptor mRNA, but expression is low which probably accounts for the failure to 
detect it in some autoradiographic studies (Sugimoto et a! , 1983). The oxytocin receptor 
also has a high affinity for A VP, which has been speculated to mediate central effects of 
both A VP and oxytocin (Elands et al, 1988). 
There are still questions concerning the central distribution of A VP-ergic cells 
and their fibers. In some cases, knowledge is lacking about the terminal sites of localized 
cell clusters, while in others the sites of the A VP-ergic fibers or terminals are known, but 
not their cells of origin. In particular, while the origin of the A VP-ergic fibers in the 
ventral hippocampus (CAl , CA3) appears to be in the medial amygdala (Caffe et al. , 
1987), the origin of the A VP-ergic fibers in the dentate gyrus is not clear. 
Immunohistochemical studies have shown A VP-ergic neurons in a variety of structures, 
such as the bed nucleus of stria terminalis (De Vries and Buijs, 1983; Caffe ' and van 
Leeuwen, 1983; Sofroniew, 1985), the ve1tical limb of the nucleus of the horizontal 
diagonal band (Sofroniew, 1985), the septum (Sofroniew, 1985), the PVN ( Buijs, 1978; 
De Vries et a!. , 1985), the SON (De Vries et a!. , 1985), the suprachiasmatic nucleus 
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(Buij s, 1978; Sofroniew and Weindl, 1980), the dorsomedial hypothalamus (Caffe ' and 
van Leeuwen, 1983; De Vries et al. , 1985), the medial amygdaloid nucleus (Caffe' and 
van Leeuwen,1983; De Vries et al., 1985; Sofroniew, 1985), the locus coeruleus (LC) 
(Caffe' and van Leeuwen, 1983; Caffe ' et al., 1985; De Vries et al., 1985; Sofroniew, 
1985), the nucleus subcoeruleus (Caffe ' et al., 1985; Sofroniew, 1985), and the spinal 
cord (Kai-Kai et al., 1986). In many of these neurons, A VP has a neuromodulatory effect 
since it produced long-lasting facilitation of the response to the excitatory 
neurotransmitter glutamate (Urban, 1987). De Vries and colleagues (1984) found that the 
distribution of A VP in the rat brain included androgen dependent pathways in which a 
higher density of A VP fibres in the bed nucleus of the stria tenninalis, the amygdala and 
the LC is found only in male rats. 
Since neuropeptides are often produced in small an1ounts and rapidly transported 
from the cell body, many of these studies used the axonal transport inhibitor colchicine to 
permit cell body staining. However, colchicine has profound effects on the ultrastructural 
features of neurons (Alonso, 1988) and can affect peptide production (Ceccatelli et al. , 
1991 ; Re 'thelyi et al. , 1991). This teclmique has been replaced by in situ hybridization 
that permits detection of cells possessing peptidergic mRNA. Hallbeck and colleagues 
(1999) used this technique to identify the distribution of neurons that may be the origin of 
AVP in the hippocampus of the male Sprague-Dawley rat. APV :mRNA labeling was 
seen in the pyramidal layer of the hippocampus throughout the CA1- CA3 fields and in 
the dentate gyrus. Thus hippocampal granule cells may produce A VP. A VP binding sites 
in the dentate gyrus are the densest within the hippocampus (Brinton et al., 1984; Phillips 
et al, 1988). 
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Studies have reported that A VP activates hippocampal neurons (Versteeg et al., 
1984; Brinton and McEwen, 1989; Giri et al., 1990; Maegawa et al., 1992), which supports 
the possible involvement of AVP in learning and memory (Bohus, 1977; Leshner and 
Roche, 1977; Bohus et al, 1978; De Wied and Versteeg, 1979). Hallbeck and colleagues 
( 1999) concluded that their findings of A VP mRNA expression throughout the 
hippocampus indicate that many of the A VP effects in the hippocampus could be e licited 
by intrinsic A VP-ergic neurons. There is also evidence that A VP is released 
extrajunctionally (Buijs and Swaab, 1979), which suggests that A VP may diffuse over 
long distances to other brain areas. Many regions containing A VP receptors lack 
A VPergic or oxytocinergic fiber innervation and some regions are devoid of receptor 
sites but instead show neuropeptide terminals (Barberis and Tribollet, 1996). Such 
observations suggest these peptides may also be involved in nonsynaptic communication. 
1.2.2 AVP and learning and memory: A history of De Wied's studies 
The earliest reports on A VP and its effects on learning and memory came from 
the classic studies by De Wied and his colleagues in the late 1960s in which he originally 
investigated the effect of a posterior pituitary lobectomy and the consequent loss of 
associated hormones on avoidance behavior. A voidance behavior is a behavioral 
response which an organism uses to prevent contact with an aversive stimulus, e ither 
active ly avoiding it or passively avoiding it through behavioral inhibition. Active and 
passive avoidance tasks were the primary paradigms used by De Wied and colleagues 
(De Wied and Bohus, 1966; De Wied,1976; De Wied, l977; Bohus, Kovacs and De Wied, 
1978) in their research on A VP and oxytocin and memory processes. These consisted of 
multi-trial active avoidance tasks like the pole jump and the shuttlebox tasks, and the 
sing le-trial passive avoidance task. Such tests reflect the ability of the animals to handle 
sudden and dramatic changes in their environment. In 1965, De Wied reported that a 
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conditioned avoidance response is extinguished at a much more rapid rate with the 
removal of the posterior pituitary lobe. The lobectomy increased the rate of extinction of 
the shuttlebox avoidance training response while a relatively crude extract called pitressin 
tannate, prepared from the posterior and intermediate lobes, prevented this abnormally 
rapid rate of extinction and maintained the conditioned re ponse. This extract con isted 
of the posterior pituitary hormones, A VP and oxytocin, and the intermediate lobe 
hormone melanocyte stimulating hormone. LVP was also found to inhibit thi rapid 
extinction rate when injected peripherally (De Wied and Bolms, 1966). It was concluded 
from their studies that the peptides present in the posterior and intermediate lobe of the 
pituitary are physiologically involved in maintaining, but not acquiring the learned 
avoidance response. 
Subsequently, De Wied and Bolms (1966) al o found that when rat wer treated 
with pitressin tannate, they exhibited a delay in the extinction of the active avoidance 
response and maintained the previously acquired avoidance response for a longer period 
con istent with the view that the peptides in pitressin were preserving and promoting 
long-term memory of the conditioned response. De Wied (1971) compared the effects of 
various peptides including L VP and angiotensin on acqui ition of a pole-jump active 
avoidance response in intact rats. The rationale for u ing these particular peptides was 
that they were structurally or physiologically imilar to A VP. They found only LVP 
inhibited extinction in acquisition of the pole-jump avoidance response and the critical 
period for administration was immediately or 1 hour after completion of th first 
extinction session. The authors concluded that A VP is the peptide in pitressin that 
improves retention and its long-term effect suggests an influence on memory 
consolidation. The effect did not appear to be related to the effects of A VP on blood 
pressure or carbohydrate metabolism since neither the pressor substance, angiotensin II, 
nor insulin or growth hormone had any effects on the extinction of the avoidance 
response. 
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Researchers also found long-term behavioral effects of A VP in studies involving 
passive avoidance responses in which the animal's motor activity is decreased in order to 
avoid the aversive stimulus. The passive avoidance test consists of an acquisition trial in 
which a rat receives a footshock after entering a box, and a test trial , in which latency 
time to enter the box again is measured (Ader and De Wied, 1972). The stronger the 
association of the box with the footshock, the longer the latency will be. The acquisition 
trial and the test trial are often separated by a 24-hour period. The passive avoidance test 
allows measurement of drug effects on consolidation, by administering the drug before or 
just after the acquisition trial , and retrieval , by administration before the test trial 
(Reijmers et al. , 1998). Ader and De Wied (1972) used this passive avoidance task to test 
the effects of LVP (subcutaneous) and were able to demonstrate that this A VP analog not 
only induces strengthened maintenance of a conditioned avoidance response in a multi-
trial active avoidance paradigm, but also in the single-trial passive avoidance paradigm. 
In a 1976 study by De Wied, examining the effects of A VP, intraventricular 
administration of A VP (1 ng/Jll) was given immediately (0 hours), 3 hours, 6 hours or 23 
hours after a passive avoidance learning trial. Rats given A VP exhibited longer latencies 
to enter the shock compartment relative to controls, when AVP was given immediately 
after the learning trial and 23 hours after the trial. Kovacs and colleagues (1978) tested 
L VP effects on acquisition and retention of a passive avoidance response in which rats 
were trained to escape footshock from a grid floor by jumping onto a bench; stepping 
down to the floor produced more footshock. L VP given I 0 minutes before the passive 
avoidance retention session did not influence acquisition, but facilitated retention since 
the step-down latency increased. 
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1.2.2.1 A VP's effects on memory acquisition, consolidation and retrieval 
Memory processes involve consolidation and retrieval of acquired information. 
Studies have exan1ined the role of A VP on both consolidation and retrieval memory 
processes as well as acquisition in an effort to distinguish its specific role. 
Bohus and colleagues (1978) studied time gradient effects of icv administration of 
A VP on retention of a passive avoidance response. A VP significantly prolonged reentry 
latencies relative to the controls and demonstrated a time dependent facilitation. A VP 
was most effective when injected immediately posttraining (consolidation effect) or I 
hour prior to the 24-hour retention test (retrieval effect). These results were similar to 
those of the 1976 study previously described . Bohus and colleagues (1978b) investigated 
both peripheral and centrally administered A VP and found no effect on acquisition, but 
significantly delayed extinction on both active and passive avoidance tasks. The 
observation that the retention effects occur at a much lower dose centrally then 
peripherally is consistent with the notion that A VP exerts its effect by influencing central 
rather than peripheral receptor sites. 
Other researchers studied the effects of A VP on retrograde anmesia to exan1ine 
effects on memory retrieval. Retrograde an1nesia refers to the inability to remember 
experiences that occurred just before a temporary but severe disturbance of the normal 
physiological activity of the brain (McEwen 2004). The amnesia can be produced by 
postlearning or preretention application of a variety of treatments that disrupt neural 
activity, such as carbon dioxide (Rigter et al , 1974; Sato et al, 2004), electroconvulsive 
shock or pentylenetetrazole (Book in and Pfeifer, 1978) or by inhibiting protein synthesis 
using puromycin. There is a debate about whether the amnesia produced is due to 
disruption of memory consolidation, in which short-term memories are changed into 
permanent long-term memories, or due to an impairment of memory retrieval because of 
the demonstrations of spontaneous recovery from this anmesia (Davis et al. , 1971 ; Miller 
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and Springer, 1973). Rigter and colleagues (1974) tested the ability of DG-LVP to 
reverse retrograde amnesia induced by carbon dioxide treatment using a single trial step-
through passive avoidance task. They found that the amnesia was reduced when DG-LVP 
was given before the training trial, the test trial, or both. Such results seem to indicate that 
the peptide protected memory consolidation, because of the peptide's antiamnestic effect 
when given before training, and memory retrieval because of its antiamnestic effect when 
injected before the test trial. 
Bohus and colleagues (1982) found an A VP-induced reversal of retrograde 
amnesia when AVP was microinjected into the dentate gyrus of the hippocampus or into 
the central amygdala. They also found that icv A VP (1 0 ng) or subcutaneously (2 ~Lg) 
injected A VP resulted in an antiamnestic effect on pentylenetetrazole-induced amnesia in 
a single-trial passive avoidance task. Such findings together suggest that the dentate 
gyrus or amygdala could mediate the consolidation and/or the retrieval effects of A VP. 
1.2.2.2. Peripheral and Central effects of A VP on Memory 
The pioneering work by De Wied and colleagues produced some controversy 
mainly due to the difficulty in separating peripheral from central effects. It was suggested 
that changes in arousal from the action of peripheral A VP on blood pressure might act as 
an additional reinforcement in aversive memory tasks so the peripheral effects may 
mediate the apparently positive effects of A VP in the modulation of memory processes. 
Thus studies were needed to determine whether the behavioral effects of A VP could be 
produced without the pressor or peripheral effects. Studying AVP fragments provided 
one way to address this issue. 
These investigations revealed that the more powerful peptide effects on 
conditioned avoidance behavior were found with C-terminal fragments of A VP (De Wied 
eta!., 1987). The AVP fragment desglycinamide (DGAVP) and AVP (4-8), in particular, 
exhibited almost no peripheral effects, but potentiated the consolidation and retrieval 
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processes in an avers ive memory task (De Wied et al. , 1984; Gaffori et al. , 1985). A VP 
(4-8) appears to be the active sequence of the DGAVP molecule . 
Gaffori and De Wied ( 1986) investigated the time periods fo r the modulating 
effects of A VP and several analogues with a sc injection (3 !!g) in rats in a passive 
avoidance paradigm. AVP 4-8 and A VP 5-8 were most active when given immediate ly 
after the learning tri al; DGAVP and AVP 5-9 were most acti ve when given 23 hours after 
the learning tria l while I -deamino-8-D-arginine-vasopressin (DDA VP) and A VP 4-9 
were most active when given immediately and 23 hours after the learning tri al. So the 
analogues seem to have different time-related effects on memory. 
Car and Murtazina ( 1994) investigated the effects of A VP and its analogue 
([d(CH2) 1/5 ,Tyr(Me)2]A VP) in a lever-touch autoshaping model of learning and 
memory. The analogue lacks endocrine and pressor acti vity. ICV injection of I pg AVP 
and 2 pg of the ana logue 24 hours prior to extinction did not alter the response in 
extinction sessions compared to the saline controls, but in the retention test, a higher level 
of correct responses in analogue-treated rats was found . T he behav io ral processes 
involved in the ex tinc tion of an operant response are not c lear. During the earl y stages of 
extinction , the level of responding may possibl y refl ect the strength of retention of the 
conditioned response, so extinction could be considered as a measure of memory for the 
original task. The de lay in extinction, seen in other studies, does suggest a retention-
enhancing effect of A VP. But as extinction continues, the decline in response over a 
period of time can itself be considered as a fo rm of learning. 
In a tudy by Kumar and Karanth ( 1995) animals conditioned in a T-maze with 
appetitive ( I 0% sucrose) and aversive (2.0 rnA foo ts hock) events were administered (icv) 
a single dose of 2.5, 5, I 0 or 20 ng A VP 20 minutes before testing. In the retention test 
conducted with the same training apparatus 72 hours afte r condi tioning, the peptide 
treated rats showed a dose-dependent increase in late nc ies to enter the prev ious ly shocked 
goal arm with the absence of such a diffe rence in responding to the non-shocked goal 
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arm. This differential response was not observed in saline-treated rats. The ICY tudies 
and analogous studies are the main evidence that pe ripheral effects are not necessary fo r 
memory improvement. 
The physiological significance of central A VP modul ation has also been 
demonstrated using specific antisera. An antiserum temporaril y blocks the biological 
acti vity of A VP in the brain when g iven icv and results in a time-dependent decline in 
memory processes (Van Wimersma Greidanus & De Wied , 1976; Van Wime rsma 
Greidanus et al. , 1975). Wimersma Greidanus et al. (1975) found that icv administration 
of A VP antiserum either 30 minutes before or immediate ly after the learning tri al induces 
a marked deficit in a one-tri al passive avoidance task, when tested 24 or 48 hours later, 
but not when tested 2 minutes or I hour after the learning tri al. This suggests that 
memory rather than learning processes are disrupted by A VP inacti vity. Kovacs and 
colleagues (1 982) examined the effect of intraventricular anti-A VP serum and also 
microinjections into the dentate gyrus on pass ive avoidance behavior. When injected 
immediate ly afte r the learning trial the anti -A VP serum resulted in marked impairment of 
the behavioral performance for the dentate gyrus group. Injection into the cerebral 
ventric les only affected pass ive avoidance re tention when given at a higher dosage than 
that given in the dentate gyrus group. This indicates that the effects of the hippocampal 
application cannot be explained by leakage to the brain ventricul ar system and the 
neutralization of the A VP must have occurred within the hippocampus. 
Co llective ly, it seems that under normal c ircumstances AVP is primaril y involved 
1n memory processes of consolidation and retrieval and not in the initial phases of 
memory processing like attention , arousal and motivation. However, under certain 
conditions, A VP does influence learning through pe ri pheral effects. Gaffori and De 
Wied, (1985) found e nhanced avoidance learning on a pole-jump task when AVP (3 f.l g 
sc) was given at a high dose immediately before the training. Suc h enhancing effects 
were not seen with a high dose of the fragment DG-A VP which is devoid of endocrine 
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effects. Arousal level effects of the peptide have also been found to enhance an other 
AVP effect on learning (Skopkova et al, 199 1). Acquisition of a shuttlebox avoidance task 
was fac ilitated in low-acti vity rats with the lowest dose of DG-A VP (0.1 !J g sc) but not in 
high activity rats as prerated on the basis of ex ploratory behavior. A VP also improves 
acquisition of a new behaviour whe n the subject's ability to process info rmati on and 
learning is impaired, as in completely hypophysectomized rats ( De Wied 1965; Bohus et 
al, 1973; De Wied and Gispen, 1977),. 
1.2.3 Brain sites involved in the A VP influence on memory 
Lesion and microinjection techniques have provided insight into the localization 
of the brain sites involved in medi ating the effects of A VP on memory storage and 
retrieval. In a study by V an Wimersma Greidanus et al. ( 1974), the mediodorsal thalamus 
and the parafascicula r nucleus were lesioned resulting in an impairment in acqui sition of 
a pole-jump avoidance task. LVP (sc) revered this impairment. When the parafasicul ar 
nucleus alone was lesioned, there was no effect. Thus it was concluded tha t the 
parafas icular region and the mediodorsal thalamus were not essential fo r the A VP effects 
to occur. On the other hand, limbic system sites such as hippocampus (Van Wimersma 
Gre idanus et al. , 1976), septal region (Van Wime rsma Greidanus et al. , 1975b), and 
amygdala (Van Wimersma Greidanus et a l. , 1979b) do play a ro le in mediating the 
e ffec ts of AVP on re tention behavio r. LVP (3 J..Lg and 9 J..Lg sc) given before extinction 
failed to maintain avoidance responding in rostral septal lesioned subjects, which 
involved complete destruction of the medial septal nucleus and partial destruction of the 
lateral septal nucleus and nucleus accumbens (Van Wimersma Greidanus et al. , 1975b). 
An anterodorsal hippocampal lesion acce lerated the rate of extinc tion in a po le-jump 
shock avoidance response which was unaffected by LVP (V an Wimersma Greidanus et 
al, 1976) . Lesions to the central and basolateral amygdaloid complex also prevented the 
inhibitory effects of DG-LVP on extinction of a po le-jump avoidance task (Van 
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Wimersma Greidanus eta!, l979b). These results suggest that an intact septal region and 
anterodorsal hippocampal region is important for mediating the A VP-induced prolonged 
extinction in the pole-jump avoidance task. 
Ibragimov ( 1990) a lso found enhanced acquisition of an active avoidance reflex 
response after the hippocampal administration of A VP agon ists 60 minutes before each 
sessiOn. 
In a study examining immunoreactive A VP (irA VP) content in various midbrain-
limbic system sites following footshock, Laczi and colleagues ( 1983a,b) found that 
irA VP levels increased in both the LC and the central amygdala, but decreased in the 
lateral septum and hippocampus. They also found that the hippocampal irA VP content 
was related to avoidance performance in that good avoiders exhibited reduced 
hippocampal irA VP content. 
Kovacs and colleagues (Kovacs et al., 1979; 1982; and 1986) found that 
postlearning and preretention microinjection of 20-25 pg A VP or A VP fragments into the 
dorsal or ventral hippocampus resulted in an improvement of retention of pass ive 
avoidance behavior. When 50 pg AVP was microinjected into midline dorsal septal 
nuclei or dorsal raphe nucleus, retention was enhanced by increased reentry latency at the 
24 hr retention test but not at 48 hr. AVP (25pg) microinjected in either the central 
nucleus of the amygdala or the LC failed to have any effect on consolidation. Such doses 
are behaviorally ineffective when injected into the lateral ventricle (Bohus et al, 1978b). 
The results of these experiments as well as those of Bohus et al. ( 1982) sugge t that 
selective brain sites may mediate both consolidation and retrieval effect of A VP while 
other sites may mediate e ither consolidation or retrieval. As previously discussed, Bohus 
and colleagues ( 1982) examined the abi lity of AVP to reverse retrograde amnesia in a 
step-through passive avoidance task when injected into specific brain structures. The 
rationale for this is that the amnesia is seen as an impairment of retrieval. A VP ( I 0 ng 
icv) reversed the severe amnesia, induced by penetylenetetrazole, when injected into 
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either the central amygdaloid complex or the hippocampal dentate gyrus. A VP injection 
into the dorsal septum and dorsal raphe nucleus fai led to reverse the amnesia. The 
findings suggest that the hippocampal dentate gyrus mediates the effects of A VP in both 
memory consolidation and retrieval, but the dorsal septal nucleus and dorsal raphe 
nucleus are involved in the effects of A VP on consolidation, but not retrieval. The 
amygdala is suggested to be involved in the retrieval process and not consolidation. 
1.2.3.1 FOS protein and A VP 
One of the consequences of neuronal excitation by A VP, acting through V 1 
receptors, is the activation of the immediate earl y gene c-fos. Studies have shown that the 
icv injection of A VP stimulates c-fos mRNA expression in the hippocampus and lateral 
septum (Andreae and Herbert, 1993; Giri et al., 1990). This provides evidence that the 
central action of A VP must take place in these structures. The increase in c-fos message 
is rapid and short term, thus it became more practical to measure the gene product, Fos 
protein, since protein expression often is of longer duration. 
Studies using Fos protein confirm the differential sensitivity of the hippocampus . 
Fos protein was measured following an icv A VP injection in unconditioned and 
conditioned mice (Paban et al., 1999). The conditioned mice learned a visual 
discrimination task and were then given icv A VP (2 ng) while the unconditioned mice 
just received the icv A VP injection. The unconditioned mice showed an increase in Fos 
protein expression in the dentate gyrus over the entire septotemporal area, the CA 1 and 
CA3 hippocampal fields, also through the lateral septum, the bed nucleus of the stria 
terminalis, and the basolateral and central amygdaloid nuclei. In contrast, in the 
conditioned mice, the increase in Fos expression was specifically detected in the dentate 
gyrus along its septotemporal axis, the ventral CA3 hippocampal field and the lateral 
septum. Such specific Fos protein activated sites following post-training icv AVP 
supports the view that these specific areas (septum and hippocampus) are involved in the 
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enhancing effect of AVP on memory consolidation in visual discrimination learning. The 
conditioned mice tended to have specific Fos expression on ly in areas specific to 
hippocampus, a central target structure of the effects of A VP on memory processes. The 
authors hypothesized that the Fos expression seen in the lateral septum is a consequence 
of the hippocampal activation based on the neural connections between these two 
structures (Paban et al., 1999) 
1.3 A VP in vitro and in vivo studies 
Studies conducted by Joels, Urban, De Wied and other colleagues have u ed 
e lectrophysiological techniques in both in vivo and in vitro paradigms to investigate the 
putative neurotransmitter-neuromodulator functions of A VP. Joels and Urban ( 1982) 
investigated the actions of A VP on single cells in the lateral septal complex and the 
dorsal hippocampus. The iontophoretically applied AVP induced significant excitation of 
the cell s of lateral septal complex and the dorsal hippocampus. Such excitation of 
hippocampal cells was also seen in a study by Muhlethaler and Dreifuss ( 1982) and also 
reported in ventral hippocampal cells (Urban and Killian , 1990). A VP enhanced 
responsivity of glutamate-induced activity in both structures, especiall y in those cells 
which did not respond to AVP on its own. This suggests a neuromodulatory role of A VP. 
This modulatory influence on lateral septal neuronal responsivity was found to persist up 
to 15 minutes after termination of A VP treatment in a follow-up study by Joels and 
Urban ( 1984). 
Chepkova et al. (1995) carried out CAl neuronal recording in slices for 15 
minutes in a 0.1 mM solution of either A VP or the AVP fragment (4-8) both of which 
resulted in an increase in the amplitude and slope of the Schaffer collateral EPSP in 21 
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neurons tested. The peptide-induced increase in EPSP slope reached a maximum 30-45 
minutes after peptide application. In 14 of these neurons the increase in EPSP slope 
lasted throughout the 60-120 minute washout period. In 7 of these, the mcrease was 
followed by a gradual decline to the pre-administration level. 
A VP also increases the perforant path evoked EPSP elicited in the granule cell 
body layer of the dentate gyrus in vitro (Chen et al. , 1993). In this study A VP was studied 
in the presence of varying concentrations of calcium. The effect was dose-dependent and 
peptide specific since there was no effect with oxytocin infusion (Chen eta!, 1993). This 
effect of A VP was blocked by a Vl receptor antagonist demonstrating that the long-term 
enhancement induced by A VP is receptor- specific (Chen et al , 1993 ). 
In the presence of 1.5 mM calciwn, 100-500 nM A VP applied for 15 minutes 
increased the amplitude and slope of the EPSP which persisted for the 60 minute period 
of exposure. This enhancement also lasted in the absence of A VP for 60 minutes. In the 
presence of 2.5 mM calcium (a supraphysiological concentration) similar concentrations 
of AVP decreased the amplitude and slope of the EPSP. Thus the potentiation occurred 
only at physiological levels of calcium. This implicated dependency of long-term A VP-
induced potentiation on extracellular calcium concentration was also observed in the 
expression of A VP-induced modulation of NE effects, where in the presence of 0.8 mM 
calcium AVP potentiated noradrenergic-induced cAMP formation, while in 2.5 mM 
calciwn A VP induced a depression of noradrenergic-induced cAMP formation (Brinton 
& McEwen, 1989). Neuromodulation of NE and A VP is further discussed in the 
following section. 
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Calcium is c ritical in the development of the CNS (Berridge, 1993) and the 
various types of calcium channels play a critical role in neurite growth, gene expression, 
and modulation of learning and me mory (Bliss and Collingridge, 1993; Goelet et al, 
1986). Calcium is a c ritical compone nt of LTP express ion and maintenance (Dunwiddie 
and Lynch, 1979) and because calcium regulates expression of long lasting A VP 
potentiation or depression (depending on the concentration) we can speculate that the 
mechanism is a calcium-dependent mechanism that is common to many forms of LTP 
previously studied (Dunwiddie and Lynch 1979 ; Malenka, 199 1; Son and Brinton, 1998; 
Son and Brinton, 2001 ). 
Dubrovsky and colleagues (2003) examined icv A VP ( I )..I g) in the ane the tized 
rat with tetanic stimulation and found that icv A VP produced a significant enhancement 
of tetanus-induced pote ntiation in the amplitude of both EPSP slope and population 
spikes of the perforant path-evoked potenti als in the dentate gyrus. The effects were 
evident I minute afte r tetanization . The population spike amplitude increased 
continuously for the 2 hour recording time, reaching values I 00% above baseline level. 
Without te tanization, dentate gyrus-evoked potenti als were often of higher ampli tude 
than baseline, but these values did not reach statistical signi ficance. 
1.4 Neuromodulation of NE and A VP 
A neuromodulatory action of a ne urotransmitter enhances or dimini shes the effect of 
another neurotransmitter on a given target neuron by means of an interaction between the 
receptors for the two neurotransmitters . A neuromodulatory action is mediated by 
metabotropic recepto rs. It occurs when G-protein coupled transmitter effects produce 
long-lasting neuronal changes that influence the normal responses to a fas t ionotropic 
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neurotransmitter. A neuromodul atory effect is of slow onset and results in a longer lasting 
metabolic and structural effect that alters the transmitter output or respons ivity of the 
target neuron to other transmitter inputs (McEwen, 2004). This provides a mechanism by 
which biochemical association could occur. A neuromodulatory inte raction that has been 
linked to memory function and which has been the subject of biochemical investigation is 
the interaction between NE and A VP (Church, 1983; Brinton, 1990). This is also the 
focus of the present e lectrophysiolog ical study. 
There has been extensive research on the possibility that the three brainstem-
telencephalic monoaminergic projection systems, NE, dopamine (DA) and seroton in (5-
HT) modulate memory processes (Hasselmo, 1994; Myhrer, 2003). Of particular 
importance to this thesis, is the noradrenergic projection system that originates in the cell 
populations locali zed in the LC of the pons and the LC fibres proj ecting to telencephalic 
structures implicated in memory processing for example, the hippocampus and the 
septum. These same structures receive terminals from ex trahypothalamic A VP-
containing fiber projections or conta in A VP receptors. As outlined previously, there is 
support for the propositions that noradrenergic projections facilitate memory processing 
(Borrell et al, 1983, Ellis, 1985; Sara, 1985 ; Lee and Ma, 1995), at least in some types of 
learning and memory. Studies by De Wied and Kovacs and colleagues have investigated 
the possibility that the central neurohypophysial peptidergic fiber syste ms modul ate 
memory processes by influencing neurotransmission in these brainstem-telencephalic 
monoaminergic projections. Their research has specificall y focused on the fi ber 
projections containing NE or DA. 
Kovacs et a!. ( 1977) carried out behavioral and biochemical experiments to 
investigate an A VP and catecholamine interaction in memory processing. In the 
behavioral experiments, the catecholamine synthesizing enzyme inhibitor, alpha-methyl-
p-tyrosine methylester (MPT) was injected alone or in combination with LYP and 
learning and retention of a bench-jump pass ive avoidance task was assessed. The 
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treatment had no effect on learning but the MPT and LVP combination prevented the 
LVP-retention effect. The biochemical experiments tested if LVP influenced NE through 
the study of NE levels after L VP injection in different areas of the brain . The NE 
turnover rate was measured in these structures. LVP was not found to affect NE content 
in the hypothalamus, septum or stri atum but it increased the MPT -induced disappearance 
of NE in the hippocampus. This study supports the findings that A VP plays a role in 
retention and also suggests that NE, or catecholamines in general, may be involved in 
med iating AVP's effect since inhibiting cathecholamine synthesis prevented A VP 
enhancement of retention . 
Kovacs et al. ( 1979a) examined the effects of A VP (not L VP) on memory 
consolidation in a passive avoidance task and on NE neurotransmission. A VP injection 
into the dentate gyrus of the hippocampus facilitated passive avoidance memory 
con olidation and increased utilization of NE in that structure and also in the dorsal septal 
nuclei. Kovacs, Bohus and Versteeg ( 1979b) reported that intra-dentate injections of 25 
pg of AVP were effective in improving task retention of passive avoidance behaviour and 
that NE depletion , using 6-0HDA lesions of the dorsal noradrenergic bundle, blocked 
this effect. The results of thi s study led the authors to conclude that the dorsal 
noradrenergic bundle-LC-NE fiber pathway is important for the expression of A VP-
induced facilitation of passive avoidance memory consolidation and also that the 
interaction between A VP and the dorsal noradrenergic bundle pathway-NE fiber system 
occurs in the region of the fiber te rminals of this pathway in the dentate gyrus. 
Church ( 1983) examined the influence of LVP, NE and their combination on the 
stimulation of cAMP accumulation in the hippocampal slice. He found that NE produced 
a 4-5 fo ld increase in cAMP concentration, but no effect was seen with L VP alone. 
However, L VP potentiated the cAMP stimulative effect of NE twice as much as NE 
alone. In support of these findings, another study found that anti-A VP serum, which 
reduces endogenous A VP, injected into the hippocampus and septal area attenuated 
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retrieval and consolidation and also showed that A VP enhances NE turnover in these 
structures (Veldhuis e t al. , 1987). 
Tanaka et a!. ( 1977) al so studied icv A VP effects on catecholaminergic rates of 
utilization in various brain sites. Their study supports the lesion and micro injection 
studies described previously in that the same regions showed increased A VP- induced 
catecholaminerg ic utilization. These regions included the hippocampus, parafaciscular 
thalamus, dorsal septal nucleus, LC and dorsal raphe nucleus . 
In a later bioc hemical investigation of this A VP dependency on NE, Brinton and 
McEwen ( 1989) found that A VP not onl y significantly potentiated NE-induced cAMP 
formation but the potenti ation was selective fo r ~-adrenoceptor-stimulated adenylate 
cyclase. It was later found that AVP-induced potenti ation was a Ca2+-dependent process 
and could be blocked by an antagonist to the calcium-binding protein , calmodulin 
(Brinton and Brownson, 1993). So it has been proposed that NE re lease into the dentate 
gyrus medi ates the A VP memory enhancement. 
The microinjection, lesion and biochemical studies provide evidence fo r the 
theory that the memory-modulating effects of AVP involve brainstem and fo re brain 
limbic system structures that are implicated in memory processing. These studies support 
the hypothesis that the interaction of A VP and central catecholamine neurotransmitters, 
in particular, NE, mediate A VP's influence on memory processing with targeted studies 
identifying the dentate gyrus as a c ritical structure in this interaction. 
The purpose of the present study is to ask if A VP plays a role in the potentiation 
of glutamatergic perforant path input to the dentate gyrus in vivo and to determine 
whether that potentiation is dependent on local noradrenergic P-receptor activation. In the 
first experiment, ure thane-anaesthetized rats are given icv infusions of A VP while 
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responses to perforant path input are monitored in the dorsal dentate gyrus. In the second 
experiment the procedure is repeated but two micropipettes, one fil led with saline and a 
second filled with the ~-receptor antagonist, propranolol, are used to monitor the 
perforant path evoked potential responses before and fo llowing icv infusion of A VP. A 
third experiment examined icv infusion of the AVP fragment, DGAVP which selectively 
activates the V 1 A receptor, while responses to perforant path stimulation were again 
monitored in the dorsal dentate gyrus. 
METHODS 
All procedures and methods were conducted in accordance with the guidelines and 
procedures of the Canadian Council on Animal Care and were approved by the Memorial 
University of Newfoundland Institutional Animal Care Committee. 
Experiment 1 
Subjects: 
Twenty male Sprague-Dawley rats weighing 250-300 g; Memorial University 
vivarium, were anesthetized with urethane (1.5 g/kg; i.p.). 
Surgical procedure: 
When tail pinch no longer caused a response, the head fur was shaved, and the 
animal was placed into the em·bars in a stereotaxic frame, in the skull flat position. 
Temperature was maintained at 37.5 degrees Celsius with the use of a rectal probe and 
heating pad. Skin was cut along the midline and held back with forcep . Coordinates 
were mapped as follows: the cannula was targeted to the lateral ventricle at 0.8 mm 
posterior to bregma and 1.5 mm lateral; the recording electrode was targeted to the 
dentate gyrus at 3.5 mm posterior to bregma and 2.0 mm lateral and the stimulating 
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electrode was targeted to the perforant path at 7.2 mm posterior to bregma and 4.1 mm 
lateral. A stainless steel guide cannula (28 ga; Plastics One, Roanoke VA) was lowered 
into the lateral ventricle to a depth of 3.2 mm below skull surface and secured with dental 
cement to a jeweller's screw implanted into the skull. 
Recording and stimulating procedure : 
A single saline-filled glass micropipette was lowered 2.5-3 mm into the dentate 
gyrus, and a single bipolar stimulating electrode (NE- 100; Kopf) lowered 3.0 mm into the 
perforant path . Stimulation consisted of a single .2 ms square wave pulse delivered with a 
I 0 second interstimulus interval (0.1 Hz). Depths were optimized to produce a max imal, 
positive-going population spike in the dentate granule cell layer. Recordings were 
amplified by a Grass P5 series amplif ier (filte rs I Hz- 3 kHz). The s ignals were digitized 
(I 0 kHz) and stored on a compute r using the D atawave Technologies "Brainwave" 
software package. After 23-30 minutes of baseline recording, I ng (i n 2 !J.l saline) A VP 
was given icv via an internal injection cannula (40 IJ.m tip) placed into the guide cannula 
in the lateral ventricle. Infusion occurred at a rate of 2 !J.llmin. Responses were recorded 
for a minimum period of 30 minutes post-injection. 
Upon completion of the experiment, methylene blue ( I %; 2 !J.l) was delivered into 
the lateral ventricle to confirm ventricul ar placements. The animal was then sacri ficed 
and the brain fresh frozen in -72 degrees Celsius methylbutane. Cannula and e lectrode 
placements were confirmed histo logicall y. Brains were sectioned in a cryostat in the 
coronal plane (40 IJ.m thickness) and alternate sections were taken for dye verification 
(methylene blue) and electrode placements (Nissl stain). Data were included if methylene 
blue was located within the lateral ventricle. 
Experiment 2 
Subjects: 
35 
Six male Sprague-Dawley rats weighing 250-300 g; M emorial U ni versity vivarium) were 
anesthetized with urethane ( 1.5 g/kg; i.p.). 
Surgical and recording procedure: 
This experiment followed the arne surgical procedure for cannula and recording 
procedures as the first experiment, but used two recording micropipettes (40 Jlm tip ) in 
which one recording pipette was filled with saline (0 .9%) and the other filled with the 
norepinephrine ~-antagoni st, proprano lo l (50 jlM, mi xed in 0 .9% saline). T his 
methodology has been used previously to tudy local pharmacological effects in the 
dentate gyrus (see Munro et al, 200 I). The pipe ttes were placed 0 .5 mm apart in a 2 
e lectrode ho lder with each optimized fo r a positive population spike. Typical ly the 
poste rio r pipette wa more medial and deeper than the anterior one. The pipettes were 
adjusted until s imilar population spikes were recorded o n each so as to be comparable 
prior to A VP infusion. 
Experiment 3 
Three male Sprague-Dawley rats weighing 250-300 g; M emorial University 
vivarium, were anesthetized with urethane ( 1.5 g/kg; i.p.). 
Surgical and recording procedure: 
This experiment fo llowed the procedures of experiment I with the exception that 
the AVP fragment DGAVP ( 1 ng/2 Jll aline), was injected into the lateral ventricle 
instead of AVP. 
Data Analysis: 
T he Brainware Software allo wed for parameter extraction to be performed to 
measure 2 characte ristics of the response: ( I) the excitatory post- ynaptic potentia l 
(EPSP) slope - average rate of change (rise/run ; mV/ms) of the ris ing egment of the 
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EPSP, (2) the population spike- average voltage difference (mY) between the peak and 
trough of the downward deflecting spike event. Following measurement extraction of 
each waveform, data were transferred to an E xcel preadsheet program. The final graphs 
were prepared in Prism (for percentages, graphing and statistics). Paired samples t-tests 
were performed on the average 30 minutes baseline compared to the average of 30 
minutes post injection . 
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RESULTS 
Experiment 1: Response to A VP 
The effect of intracerebroventricular (icv) application of A YP on the population 
spike amplitude and the EPSP slope of the perforant path-dentate gyrus evoked potential 
was exan1ined post A YP infusion in 16 rats. 
1.1 Population spike changes 
A YP reliably produced potentiation of the population spike amplitude in 15 out of 
16 animals at the 1 ng dose (Table 1-1 and Figure 1-1 ). Fifteen of the animals infused 
with A YP demonstrated potentiation of the dentate gyrus evoked response as potentiation 
of the an1plitude of the population spike. Eleven rats showed potentiation of EPSP slope. 
Table 1-1 shows the effect of I ng A YP icv on the population spike amplitude and the 
EPSP slope in the dentate gyrus in each animal (n=16). 
In the fifteen animals, A YP increased the population spike an1plitude with a mean 
increase of 94% averaged over 30 minute post A YP. This increase typically occurred 
within 3-5 minutes and potentiation continued to rise over the 30-35 minutes post-
injection period. Individually the increase ranged from 10% to 250% at the peak in some 
experiments. The baseline mean increased from an amplitude of2.67 mY to 3.66 mY 30 
minutes post AYP application (t = 5.57; df = 14; p<0.05). One animal showed a 
significant decrease of 28% in population spike amplitude and showed no change in 
EPSP slope. 
In four experiments the potentiation was followed beyond 30 minutes and lasted 
more than 1 hour in all cases. The longest monitoring occurred in experiment 12 (Table 
1-1 or #4 in Table 1-2) which had a mean baseline (30 minutes) of 2.17 mY of the 
population spike amplitude, the 30 minutes post mean was 3.28 mY, in the next 30 
minutes block (1 hour post) it increased to 3.84 mY and in the last 30 minutes block (2 
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hours after AVP administration) the amplitude was at a mean of3.95 mV. The group that 
was followed beyond an hom (n = 4) showed a mean increase of 80% (in the 30-60 
minute block ) across animals with individual increases ranging from 41% to 246%. 
Table 1-1 .Effects of intracerebroventricular (icv) application of A VP on the population 
spike amplitude and the EPSP slope of the perforant path-dentate gyrus evoked potential 
in the urethane anesthetized rat (n = 16). 
I Single Pipette Population Spike Amplitude EPSP Slope 
Experiments (mV) (mV/mS) 
N= 16 Pre AVP Std. Post Std. Pre Std. Post Std. 
Mean Dev. AVP Dev. AVP Dev. AVP Dev. 
Mean Mean Mean 
1 0.28 0.063 0.79* 0.300 1.73 0.056 2. 19* 0.203 
2 0.64 0.138 3.10* 0.757 2.07 0.026 2.47* 0.124 
3 5.46 0.302 5.18** 0.414 2.63 0.086 2.66 ns 0.129 
6 5.90 0.269 6.32* 0.396 4.65 0.055 4.74* 0.068 
7 3.02 0.196 3.61 * 0.358 3.33 0.054 3.59* 0.099 
8 0.56 0.051 1.28* 0.374 2.21 0.095 1.94 ns 0.253 
9 2.36 0.075 3.51 * 0.337 3.18 0.029 3.46* 0.101 
10 4.38 0.039 5.01 * 0.339 3.1 6 0.082 2.78** 0.125 
11 1.25 0.344 2.32* 0.263 3.71 0.125 3.64 ns 0.071 
12 2.17 0.072 3.28* 0.626 2.34 0.060 3.18* 0.505 
13 1.13 0.061 1.83* 0.463 2.86 0.085 2.85 ns 0.089 
14 3.42 0.214 5.63* 0.883 4.51 0.126 6.06* 0.644 
15 2.67 0.163 3.96* 0.578 2.09 0.046 2.30* 0.044 
16 4.55 0.299 5.64* 0.844 5.71 0.064 6.10* 0.132 
17 2.46 0.430 2.87* 0.544 2.89 0.104 2.98* 0.133 
18 2.55 0.138 3.25* 0.715 5.27 0.108 5.86* 0.342 
Group Mean 2.67 1.72 3.66* 1.55 3.27 1.20 3.55* 1.39 
N= 16 
Data represent means in millivolts (m V) for the 25 minutes pre A VP mean and an 
average of 30 minutes post AVP (1 ng) infusion. * indicates an increase at a minimum of 
p<0.05 between pre and post means as a result of two-tailed paired t-test on raw data. ** 
indicates a significant decrease between pre and post mean responses. 
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Figure 1-1: lntracerebroventricular application of A VP induces a potentiation of the 
population spike amplitude and field EPSP slope in the urethane anesthetized rat. A) i.c.v 
A VP (arrow) induced a long-term potentiation of the dentate gyrus evoked population 
spike in the anesthetized rat (n = 15). Inset: Sample waveforms with parameter 
measurements of the dentate gyrus evoked potential before (solid line) and after (dashed) 
infusion of A VP into the lateral ventricle. Scale bar = 2 m V and 2 ms. B) 
lntracerebroventricular A VP also produced a long-term potentiation of the EPSP (n = 
II). 
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1.2 EPSP slope changes 
A VP reliably produced potentiation of the EPSP slope in 11 out of the 16 animals 
at a dose of 1 ng icv. Table 1-1 and Figure 1-1 show the effect of A VP on EPSP slope in 
the dentate gyrus across all animals (n= 16). EPSP slope increased stepwise starting 
within 2-4 minutes, peaked between 10-20 minutes and continued to be elevated over the 
typical 30 minute recording period. The baseline mean increased from 3.27 to 3.55 
mV/ms with 30 minute blocks pre and post AVP (t = 2.45 ; df = 15; p<0.05). The increase 
was an average of 20% at the peak overall from baseline with a range of a 2% increase to 
a 46% increase in individual animals. Out of the fifteen animals that showed an increased 
population spike, 11 animals or 73% showed increased slope as well. In 3 of the animals 
A VP produced a 10% decrease from baseline in EPSP slope and no change in the EPSP 
slope occurred in 2 animals. Figure 1- 3 illustrates the 5 animals that showed a decrease 
or slight change in the EPSP slope. 
The increases in EPSP slope were further followed from 75 min. to 125 min. in 
four experiments. Table 1-2 shows a mean increase of 21% in the 30-60 minute block, 
but individual animals varied, and ranged from a 5% increase to an increase of 45% 60 
minutes after A VP. With reference again to experiment 12 (Table 1-1 or #4 in Table 1-2), 
a significant increase is seen in the EPSP slope which had a 30 minute baseline of 2.34 
mV/ms, a mean of 3.18 mY/ms at 30 minutes, a mean of 3.56 mY/ms at 1 hour and a 
mean of 3. 7 4 m V /ms 2 hours post A VP. 
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Table 1-2: Effects of intracerebroventricular application of A VP on the population spike 
amplitude and the EPSP slope of the perforant path-dentate gyrus evoked potential in 4 
urethane anesthetized rats in which the evoked response was monitored for periods 
extending past 60 minutes post- A VP injection (n=4). 
Population Spike Amplitude (m V) EPSP Slope (mV/ms) 
Pre AVP Post AVP Pre AVP Post AVP 
(30mins) (60mins) (30mins) (60 mins) 
Exp. Mean StdDev. Mean Std Dev. Mean Std Dev. Mean Std Dev. 
9 2.36 0.075 3.51 * 0.699 3.18 0.029 3.37* 0.101 
12 2.17 0.072 3.63* 0.626 2.34 0.060 3.56* 0.147 
13 1.13 0.061 3.02* 0.898 2.86 0.085 2.90 0.089 
14 3.42 0.214 5.82* 0.887 4.51 0.126 6.09* 0.645 
Grp 2.27 0.106 4.00* 0.778 3.22 0.075 3.98 0.246 
% 80% increase 21% increase 
mean 
Data represent means in millivolts (m V) at 25 minutes of baseline and at 60 minutes post 
A VP (1 ng) infusion.* indicates increase at a minimum of p<0.05 between pre and post 
A VP means as a result of two-tailed paired t-test on raw data. 
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Figure 1-2 : Intracerebroventricular application of A VP induces a potentiation of the 
population spike amplitude and fie ld EPSP slope in the urethane anesthetized rat that 
lasted beyond an hour. Inset: Sample waveforms ( exp. 12) with parameter measurements 
of the dentate gyrus evoked potential before (solid line) and 30 minutes, and 1.5 hour 
after (dashed) infusion of A VP into the lateral ventricle. Scale bar = 2 m V and 2 ms. A) 
i.c.v A VP (arrow) induced a long-term potentiation of the dentate gyrus evoked 
population spike in the anesthetized rat and EPSP slope that lasted beyond an hour (n = 
4) 
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Figure 1-3 lntracerebroventricular application of A VP decreased the field EPSP slope in 
the urethane anesthetized rat (n=3) or produced little change (n=2). Inset: Sample 
waveforms for experiment 10 (Table 1-1) with parameter measurements of the dentate 
gyrus evoked potential before (solid line) and after (dashed) infusion of AVP into the 
lateral ventricle. Scale bar = 1 m V and 2 ms. 
1.3 Population spike I EPSP slope relationships 
An overlay of spike and slope (n = 16) is seen in Figure 1-4 to illustrate the 
profile of slope and spike at 20 minutes of baseline and 40 minutes after A VP. 
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Figure 1-4: A closer look at an overlay of population spike amplitude effects against 
EPSP slope effects (n= 16). 
Since A VP was found to increase the population spike amplitude and the EPSP 
slope, correlations were conducted to determine if the increase in granule cell firing (the 
population spike) was the result of postsynaptic depolarization (EPSP slope). These 
analyses were examined to determine if the effects of A VP on the population spike 
amplitude could be accounted for by the effects of A VP on the EPSP slope. 
Table 1-2 shows the correlations of population spike amplitude and EPSP slope in 
all 16 single pipette experiments. Prior to A VP, only two rats showed a significant 
increase in slope/spike correlation. Following A VP, nine rats showed significant 
correlations with all rats having significantly strong correlations for slope to account for 
more than 30% of the variance in spike. 
Thus the slope/spike relationship was variable with slope accounting for some of 
the spike change in about a third of the experiments, but not contributing to the spike 
change in the majority in others. Temporal dissociations between slope and spike changes 
can be seen in Figures 1-1 , 1-2 and 1-4. 
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Table 1-3. Correlations (r2) of population spike amplitude and EPSP slope in all 16 single 
pipette experiments. 
Single Pipette Correlation (rL) 
Experiments Pre AVP Post AVP 
N= 16 
1 0.0214 0.7152* 
2 0.0055 0.4499* 
..., 
.) 0.1201 0.7809* 
6 0.0107 0.1093 
7 0.0003 0.1239 
8 0.0093 0.0088 
9 0.0140 0.6452* 
10 0.0002 0.2409* 
11 0.2007* 0.0016 
12 0.9652* 0.8584* 
13 0.0809 0.0453 
14 0.0877 0.7814* 
15 0.0480 0.1398 
16 0.0731 0.3152* 
17 0.1213 0.0039 
18 0.1194 0.6296* 
Group mean 0.1173 0.3655* 
Data represent correlations of populations spike amplitude and EPSP slope 
* p<0.05 
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Experiment 2: Response to NE antagonist and A VP 
2.1 Evoked potential changes 
The effect of I ng A VP icv was examined on the population spike amplitude and 
EPSP slope in the dentate gyrus at both a saline and propranolol-filled (50 mM 
propranolol dissolved in saline) micropipette across 6 animals. Results are shown in 
Table 2-1 and Figure 2-1. Prior to A VP, the size of the EPSP slope, with a mean of 3.38 
mY/mS for the saline pipette and 2.26 mY/mS for the propranolol pipette, and the 
population spike, with a mean of 2.64 mY for saline and 1.95 mY for the propranolol 
pipette were not significantly different (t( lope) = 2.072, df = 5 p>0.05)and (t(spike) = 
1.091 , df=5, p>0.05). 
2.2 Population spike changes on the saline pipette 
A VP reliably produced potentiation of the population an1plitude in all six animals 
at the 1 ng dose on the saline pipette. The mean increase was 50% from baseline. The 
increase typically occurred within 2-5 minutes and continued after 30-35 minutes post-
injection. As seen in Table 2- 1, the saline filled pipette showed a population spike 
an1plitude increase from 2.64 mY to 3.59 mY post A YP (t = 5.150; df = 5; p<0.05). 
Increases ranged from 35% to 160%. 
2.3 EPSP slope changes on the saline pipette 
A VP also produced a significant potentiation of the EPSP slope in four of the six 
animals at the I ng dose on the saline pipette. The mean increase was 20%. This increa e 
typically occurred within 5 minutes and peaked at between 10-15 minutes post-injection. 
The saline filled pipette showed a baseline mean increase of3.38 mV/mS to 3.80 mV/ms 
post A VP (t= 2.699; df = 5; p<0.05). Individual increases ranged from I% to 96%. 
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Figure 2-1: Effects of saline or propranolol infusion on the perforant path-dentate gyrus 
evoked potential following intracerebroventricular application of AVP. A) i.c.v. AVP 
induced a long-term potentiation of the dentate gyrus evoked population spike (50%) on 
the saline pipette in contrast to a modest decrease (17%) on the propranolol pipette (n = 
6). Inset: Sample waveforms with parameter measurements of the dentate gyrus evoked 
potential before (solid line) and 40 minutes (dashed) infusion of AVP into the lateral 
ventricle. Scale bar = 1 mV and 2 ms. B) i.c.v. AVP produced potentiation of the EPSP 
slope (20%) in the saline pipette but showed slightly decreased EPSP slope (9%) on the 
propranolol pipette (n = 6). Inset: Sample waveforms with parameter measurements of 
the dentate gyrus evoked potential before (solid line) and 40 minutes (dashed) infusion of 
A VP into the lateral ventricle. Scale bar = 1 m V and 2 ms. 
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2.4 Population spike and EPSP slope changes in propranolol pipette 
Employing the propranolol-filled micropipette, two of the six experiments showed 
decreased population spike amplitude and four showed no significant change. Overall the 
population spike amplitude decreased from 1.95 mY to 1.68 mY, but this was not 
significant (t= 2.225 ; df=5; p<0.05) post A YP. Overall EPSP slope in four experiments 
decreased a small and significant amount in the 30 minute block post AYP, from 2.26 
mV/ms to 2.04 mV/ms post AYP (t=2.954; df=5; p<0.05). In two experiments, there was 
no change. The overall decrease was significant. The mean decrease in EPSP slope was 
9% from baseline but animals ranged from a 9% to 27% decrease on the propranolol 
pipette. 
Table 2-1 . Effects of saline or propranolol infusion on the perforant path-dentate gyrus 
evoked potential using the double pipette procedure after icv A YP administration in the 
urethane anesthetized rat. 
Double Pipette Population Spike Amplitude EPSP Slope 
Experiments (mY) (mY/ms) 
Pre Post Pre Post Pre Post Pre 
Saline Saline Prop Prop Saline Saline Prop 
3 0.54 1.40* 2.43 2.21 4.16 4.17 2.55 
5 2.71 3.63* 0.46 0.44 6.65 7.61 * 3.42 
6 3.39 5.00* 2.24 2.10* 3.18 3.56* 2.05 
7 3.40 4.05* 2.30 2.19 1.61 1.76 2.36 
8 3.88 5.18* 1.84 1.02* 1.53 2.32* 0.42 
9 1.94 2.29* 2.36 2.11 * 3.15 3.36* 2.77 
Group mean 2.64 3.59* 1.95 1.68 3.38 3.80* 2.26 
Data represent means in millivolts (mY) in the 30 minute baseline block and 30 minutes 
post A YP infusion and recorded by the saline or propranolol (50mM) pipettes. * 
minimwn of p<0.05 compared between post and baseline mean measures as a result of 
two tailed paired t-tests on individual raw data. 
2.5 Population spike and EPSP slope relationship 
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Correlational analyses of population spike and slope were performed on all 6 
animals, seen in Table 2-2. There were no significant correlations between slope and 
spike prior to A VP on the saline pipette. Four animals showed a significant increase in 
correlation from baseline A VP/Sal to post A VP/Sal. In experiment 3 and 6, the A VP/Sal 
pipette showed no correlation between the spike and slope pre or post AVP. The 
significant correlations after A VP accounted for less than 20% of the variance suggesting 
slope contributed only moderately to spike amplitude increases. There was one small, 
but significant slope/spike relationship pre A VP on the propranolol pipette, this was not 
seen after A VP. Correlations became significant in 2 other experiments but less than 20% 
of the variance was attributable to slope. 
Table 2-2. Correlations (r2 ) of spike and slope in all 6 double pipette experiments. 
Double pipette experiments Pre Post Pre Post 
AVP/Sal AVP/Sal AVP/Prop AVP/Prop 
3 0.0055 0.0377 0.1718* 0.0234 
5 0.0363 0.2105* 0.0155 0.0068 
6 0.0019 0.0438 0.0015 0.0004 
7 0.0125 0.2736* 0.0565 0.0131 
8 0.0046 0.3383* 0.0120 0.4775* 
9 0.0992 0.4296* 0.0022 0.1861* 
Group means 0.027 0.222 0.043 0.118 
Group means suggest a weak positive increase in correlation after A VP between 
slope and spike whether there was an increase (AVP/Sal) or a decrease (AVP/Prop) in 
spike amplitude. These weak correlational effects may relate to the greater range of spike 
and slope responses after A VP. 
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Experiment 3: Response to an A VP Fragment, DGA VP 
In order to assess the specificity of the original AVP actions, DGA VP, the 
selective V 1 a agonist was infused into the ventricles of 3 animals. 
3.1. Population spike changes 
DGA VP produced increases in the population spike ampli tude in all 3 animals. 
Figure 3-1 and Table 3-1 show the effects of the A VP fragment (DGA VP) on the 
population spike and the EPSP slope. 
The population spike amplitude increased with a total mean of 1.95 m V on the 
baseline 30 minute block to 3.19 m V in the 30 minute block post DGA VP. This was 
significant in a one-tailed t-test (t = 3 .148; df = 2; p<0.05). DGA VP caused a potentiation 
of the population spike amplitude after 2-3 minutes rising to 100% above baseline within 
25 minutes post infusion. Individual increases ranged from 73% to 200%. 
Table 3-l. Effects of the A VP fragment DGA VP on the population spike amplitude and 
EPSP slope of the perforant path-dentate gyrus evoked potential in the urethane 
anesthetized rat. 
Fragment Population spike amplitude (m V) EPSP slope 
experiment (mV/ms) 
Pre Std Post Std Pre Std Post Std 
DGAVP Dev. DGAVP Dev DGAVP Dev DGAVP Dev 
Means Means Means Means 
1 1.82 0.395 2.80* 0.408 2. 15 0.067 2.1 1 0.072 
2 1.84 0.103 3.86* 0.886 1.35 0.042 1.64* 0.078 
3 2. 19 0.662 2.92* 0.122 3.27 0.505 2.55* 0.535 
Group 1.95 0.208 3. 19* 0.580 2.26 0.964 2.10 0.455 
mean 
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Figure 3-1: lntracerebroventricular application of DGA VP induces a potentiation of the 
population spike amplitude but has varied effects on the field EPSP slope in the urethane 
anesthetized rat. Inset: Sample waveforms with parameter measurements of the dentate 
gyrus evoked potential before (solid line) and 30 minutes after (dashed) infusion of 
DGA VP into the lateral ventricle. Scale bar = 2 m V and 2 ms. 
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3.2. EPSP slope changes 
DGA VP did not alter EPSP slope overall post DGA VP (t = 0.5269; df = 2; 
p>0.05; see Table 3-1 and Fig. 3-1 ) . One animal showed a significant increase, one a 
decrease and one, no change. The percentage effects ranged from a 72% decrease to a 
29% increase. 
3.3. Population spike/EPSP slope relationship 
There was no significant slope/spike correlation prior to DGA VP. After DGAVP, 
a significant slope/spike effect was seen in the rat with a decrease in EPSP slope, 
although spike had increased significantly overall in this experiment. Spike increases did 
not depend on slope changes in this experiment. Table 3-2 summarizes the correlations of 
the fragment experiments. 
T bl 3 2 C a e - l . orre atwns r o spL e an d I s ope o ffl ragment expenments (n=3) 
Fragment Experiments Correlation (R2) 
Pre DGAVP PostDGAVP 
I 0.0084 0.0058 
2 0.0103 0.0110 
..., 
-' 0.0812 0.2836* 
Group Mean (n=3) 0.0333 0.1001 
4.1 Histology for Experiments 1-3 
All animals showed clear methylene blue in the lateral ventricles while waveforms were 
indicative of proper placement with the dentate gyrus and perforant path electrodes. The 
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placement of the dentate gyrus recording electrodes was also reconstructed from the 
Paxino atlas (Paxinos and Watson, 2004). Placements for each experiment are presented 
in figures 4-1 to 4-3. While it was difficult to visualize the exact tips of the glass pipettes, 
the tracks and waveforms taken together suggest placement in or slightly below the 
dorsal blade granule cell layer. In Figure 4-2 both propranolol and saline pipette tips are 
shown with the more posterior placements being propranolol. 
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Figure 4-1: Placement of recording electrode in areas of dentate gyrus in experiment 1 
showing placements of all 16 animals. 
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Figure 4-2: Placement of recording electrode in areas of dentate gyrus in Experiment 2, 
double pipette experiments, showing placements of all 6 animals. 
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Figure 4-3: Placement of recording electrode in areas of dentate gyrus in experiment 3 
showing placements of 3 animals. 
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Discussion 
A VP effects on the perforant path evoked potential in the dentate gyrus: 
Experiment 1 
Intracerebroventricular administration of 1 ng of A VP produced long-lasting 
potentiation of the perforant path evoked population spike in the dentate gyrus of the 
urethane-anesthetized rat. Potentiation of the perforant path evoked EPSP slope was also 
observed in a majority of experiments. This is the first report of A VP-induced long-
lasting potentiation in vivo. In addition, the results provide a plasticity mechanism to 
support earlier observations of icv and direct dentate gyrus A VP infusion enhancement of 
the retention for avoidance learning first reported by De Wied ' s group and recent 
observations of spatial learning enhancement (Paban et al, 2003). De Wied (I976) fow1d 
I ng of A VP given icv immediately after a passive avoidance learning trial resulted in 
longer latencies to enter the shock compatiment relative to controls the next day. 
Vasopressin injected directly into the dentate gyrus (25 pg), immediately after a learning 
trial also improved passive avoidance behaviour (Kovacs et al, 1979). A study 
exan1ining A VP in mice in the Hebb-Williams maze also found improved spatial memory 
following I ng i.c.v. and dorsal hippocampal administration, but not ventral hippocampal 
administration (Paban et al , 2003). 
While both population spike and EPSP slope were potentiated, only slightly more 
than 50% of subjects showed a significant contribution of EPSP slope to the spike 
increases after A VP based on correlational analyses. The distinct time courses of EPSP 
slope and population spike increases, the failure to see EPSP slope increases in nearly a 
third of the experiments and the lack of significant slope/spike correlations in a 
substantial proportion of subjects suggests two distinct plasticity processes are engaged 
by A VP: EPSP slope increases and population spike or excitability increases. 
EPSP slope increases in the dentate gyrus were first reported by Chen et a!. 
(1993) in an in vitro study. The present study confirms their effect in vivo. In their dose 
57 
response study they found that at 100 nM potentiation was 18% over baseline while at 
500 nM it was 50% over baseline. Our result with 2 ).ll of 500 nM A VP (the 
concentration produced by our 1 ng solution) in the ventricles was 20% over baseline 
suggesting the concentration reaching the dentate gyrus was likely less than 500 nM, but 
above threshold, since Chen and colleagues (1993) found no response at 50 nM. Their 
potentiation was only observed at physiological calcium concentrations and became 
depression at higher calcium concentrations. Both EPSP slope increases and decreases 
appeared within 5 minutes of application and lasted for the entire 60 minute recording 
time, similar to what was found in the present study. The effect was dose-dependent and 
also peptide specific since there was no effect with oxytocin infusion. This demonstrates 
that A VP is not working through oxytocin receptors in the dentate gyrus. From the 
combined in vivo and in vitro evidence we conclude that A VP increases the EPSP slope 
or synaptic strength of perforant path input. Chen et al. (1993) suggested that the most 
likely mechanism for this effect is postsynaptic, but that remains to be proven. 
As reviewed above, in the present study, the increase in the population spike 
an1plitude is not fully accounted for by the EPSP slope increase. This is consistent with 
an increase in the coupling of the EPSP to spike generation or increased cell firing 
occurring independent of changes 111 synaptic strength. Though studies on L TP 
mechanisms have mainly focused on synaptic strength changes, there are other 
determinants of neuronal plasticity, learning, and memory which include a wide array of 
ion channels expressed in the neuronal dendrites. Neuronal excitability can be defined as 
a propensity of the neuron to generate, beyond a particular threshold, an output signal 
(the action potential) from a given input signal (an EPSP). This process involves the 
opening of voltage gated ion channels in the neuronal membrane after the synapse is 
activated. This coupling concept invokes complex processes involving the voltage gated 
Ca2+, Na +, and K+ channels in the dendrites (Reyes, 2002). These channels have been 
reported to either amplify or attenuate the EPSP amplitude (Reyes 2002). Ultimately to 
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understand excitability increases such as those observed here, it will be necessary to 
identify the type of ion channel properties engaged. These channels can have a powerful 
influence over the spread of neuronal information. Persistent changes in intrinsic 
excitability have been discovered in various learning tasks (Daoudal and Debanne, 2003; 
Zhang and Linden, 2003; Alkon et al, 1985) and examined in numerous brain areas 
including cortical, hippocampal and cerebellar regions (Frick et al, 2004; Doudal and 
Debrume, 2003; Brons and Woody, 1980). Local changes in dendritic excitability have 
been identified as a second Hebbian mechanism underlying long-term associative 
plasticity (Shrader et al., 2002; Zhang and Linden, 2003). Persistent increases in 
excitability, as seen in the present study, may enhance memory ru1d retrieval of specific 
information. 
An alternative view of the EPSP slope and spike discrepancies may relate to the 
complexities of the perforant path evoked potential and will be considered in the next 
section discussing the role ofNE in the observed effects of AVP. 
Two other studies have examined AVP effects in vivo in the dentate gyrus. Wang 
et al (2001) examined whether the impairment of synaptic plasticity induced by 
aluminum could be reversed by peripheral LVP (which has actions similru· to A VP) 
treatment combined with tetanic stimulation. It was found that aluminum significantly 
reduced the amplitudes of both EPSP and population spike L TP in the dentate gyrus. 
After the application of LVP, the range of synaptic plasticity (which they identified with 
population spike LTP or LTD; EPSP slope data were not provided for the L VP treatment) 
in aluminum-exposed rats increased from 38% to 174%, which was similar to that in 
control rats (161% ). It was suggested that A VP could reverse aluminum-induced 
impairment of synaptic plasticity. Most importru1tly for the present study was the 
observation that both the EPSP slope and the population spike were enhanced by L VP in 
control rats when given an input output curve of single pulse stimuli . Thus, although the 
investigators did not follow the effects of L VP over time they found a similar potentiation 
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ofEPSP slope (~50% maximal) and spike (~150% maximal) as found here in Experiment 
1. 
Somewhat in contrast is an in vivo study by Dubrovsky and colleagues (2002), 
also using tetanic stimulation, but in combination with 1 ~g of icv A VP. They reported a 
potentiation of the perforant path-evoked EPSP slope and spike amplitude beyond control 
L TP levels when tetanization was given in the presence of icv A VP (I ~g/~1). Both EPSP 
and population spike enhancement increased steadily within 15 minutes of application 
and continued to increase for 2 hours of recording time reaching 100% above baseline. 
Thus, AVP enhanced the LTP effect as also reported for spike amplitude by Wang et 
al.(200 1 ). Without tetanization, A VP infusion was associated with higher amplitudes than 
baseline, but the changes were not statistically significant. The lack of A VP effects 
without tetanization may be due to the much higher dose (1000 fold) used by Dubrovsky 
as compared to both Chen' s in vitro study (100-500 nM) and our in vivo study (500 nM 
or 1 ng/2 ~1). 
Inverted U curve effects have been found for A VP, both in terms of modulating 
cAMP and in terms of behaviour. An inverted U-shaped dose-response relationship was 
observed for heart rate, core temperature, gross activity, locomotion and rearing 
behaviour which all increased from low to moderate dose (1 - 10 ng) and declined after 
higher doses of A VP (30-1 00 ng) (Dian1ant and De Wied, 1993). A similar relationship is 
also seen in a study of the effects of lysine vasopressin and response prevention on the 
shuttlebox avoidance paradigm (Hagan et al, 1982). Both high and low doses caused an 
inhibitory effect while moderate doses facilitated avoidance behavior. A VP 
neuromodulation of NE-induced cAMP accumulation in vitro resulted in an inverted U 
shape within a concentration range of 10-1000 nM. Lower concentrations (50 - 250 nM) 
of AVP potentiated NE-induced cAMP accumulation while higher (1000 nM) did not 
potentiate. Brinton and colleagues (1994) examined AVP activation of calcium signalling 
pathways in cultured hippocampal neurons and found that exposure of hippocan1pal 
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neurons to A VP induced inositol-1-phosphate accumulation which was concentration 
dependent and exhibited a steep inverted U curve that included stimulation and inhibition 
of inositol -!-phosphate accumulation. The biphasic characteristic of vasopressin is not 
unique to its neuromodulatory effects. Lower concentrations of A VP facilitated neurite 
growth in cultured embryonic neurons while higher concentrations inhibited neurite 
outgrowth (Brinton and Gruener, 1987). Such a bell-shaped dose-response curve is 
characteristic of other substances that affect memory consolidation and retrieval such as 
NE which also favors memory enhancement at low to medium doses but depresses 
memory at high doses (Izquierdo 1989). 
Evidence for an inverted U curve in electrophysiological potentiation effects with 
dosage of a vasopressin agonist comes from a CAl study by Chepkova, Kapai, and 
Skrebitskii (200 1 ). They reported enhanced population spike amplitude with an A VP 
fragment, AVP 4-9 in the Schaffer collateral-pyramidal CAl cell system. Here they 
studied the effects of treatment with A VP 4-9, at varying dosages, on LTP induced by 
short- and long-term high frequency stimulation. Short term L TP became long-term and 
was maximal (1 00%) in the presence of 1 ~M A VP 4-9, but decreased in magnitude at a 
lower concentration (1 ~M) and at a higher concentration of AVP 4-9 (5 ~M). The 
modulating effect of A VP 4-9 was also found to depend on the intensity of the high 
frequency stimulus where it only significantly facilitated weak high frequency 
stimulation. This suggests that A VP 4-9 facilitates LTP but also modulates its amplitude 
depending on the intensity of the presynaptic activation at least in the CAl region. 
There was no facilitation of spike amplitude without LTP at the dosage of the 
A VP fragment used, but the authors had reported earlier that both A VP and A VP 4-8 
produced potentiation of EPSPs to Schaffer collateral input and also lowered the 
threshold for firing and increased cell excitability in CA 1 pyramidal cells. These effects 
were not blocked by NMDA blockers or GABA A blockers. The EPSP enhancement and 
cell excitability effects were separable in that not all cells that showed enhanced EPSPs 
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showed increased cell excitability and the time course of the two effects in a given cell 
could differ. A similar pattern of A VP effects on intracellularly recorded EPSPs and cell 
excitability has also been reported to fimbria fornix input in the lateral septum (Urban 
and De Wied, 1986). 
The effects seen here in the dentate gyrus at the population evoked potential level 
parallel these earlier intracellular observations in related septohippocampal areas and 
suggest that A VP promotes an enhanced synaptic response to glutamate input and m 
parallel lowers the threshold for cell excitability or enhances slope/spike coupling. 
The present observation of electrophysiological A VP enhancement effects in the 
dentate gyrus is also consistent with reports of cfos activation in the dentate gyrus with 2 
ng A VP administered icv in either unconditioned or conditioned mice (Paban et al , 1999). 
A direct test of the difference between the negative Dubrovsky result with A VP 
alone and the present study would require a systematic dose-response investigation. In 
the present study 1 ng icv was selected as it is the dose DeWied originally found to be 
effective in learning and memory studies as noted above. A dose response study 
examining A VP icv (1 ng- 200 ng) and differential effects on abnormal behaviours such 
as barrel rotation and crouching (Boakes et al , 1985), found that doses of 10 ng and higher 
resulted in abnormal behavior with convulsions starting at 100 ng. These results argue 
against the use of high doses in assessing synaptic plasticity promotion in normal 
learning and memory by A VP. 
B-Adrenoceptor mediation of A VP effects: Experiment 2 
In the second experiment we tested the hypothesis that NE ~-receptors in the 
dentate gyrus are critical for EPSP and spike potentiation effects by using the double 
pipette teclmique with propranolol (50 mM) and saline filled recording pipettes together 
with the icv administration of 1 ng A VP. Our study showed that 6/6 experiments 
significantly increased in population spike an1plitude on the saline filled pipette post 
A VP. There was no significant increase in spike amplitude on the propranolol pipettes in 
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the same experiment and in two cases there was a small, but significant, decrease in 
population spike size. Thus, population spike increases by A VP require ~-adrenoceptor 
activation. The observation of decreases is consistent with an earlier report (Harley and 
Evans, 1988) using locus coeruleus activation in the presence of intra-dentate propranolol 
and finding a decrease in spike size that was related to activation of a adrenoceptors. The 
possibility that A VP affects the release of norepinephrine so that an imbalance of a and ~ 
adrenoceptor activation could be occurring will be discussed later in this section. 
Four of the six rats showed a significant potentiation of EPSP slope on the saline 
pipette, while two others did not. Three of the four that increased also had a significant 
but small (.2-.4) positive correlation between slope and spike after A VP. This pattern of 
slope and spike results on the saline pipette replicates that of Experiment 1. A VP can 
induce increases in both the EPSP slope and the population spike. The increases in spike 
size are the most consistent. EPSP slope increases only partially account for the spike 
increases observed supporting the initial hypothesis that there may be two mechanisms 
for A VP effects in dentate gyrus. 
EPSP slope increases did not occur on the propranolol pipette and in tlu·ee 
experiments EPSP slope showed a significant decrease. Slope spike correlations were 
rarely seen on the propranolol pipette. In one experiment both slope and spike decreased 
on the propranol pipette, while both increased on the saline pipette, but the only 
significant slope/spike correlation occurred on the saline pipette. In only one case was 
there a significant increase in the slope/spike correlation after A VP on a propranolol 
pipette suggesting slope was contributing to the decrease in spike size. 
Thus, NE ~-adrenoceptor activation is required for both the EPSP slope and spike 
potentiation effects seen in the dentate gyrus with central A VP activation. The weak 
correlations between the EPSP slope and population spike effects suggest NE also 
operates on synaptic plasticity through two separate P-adrenergic dependent mechanisms. 
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Church (1983), Brinton and McEwen (1989) and Brinton, Thompson and 
Brownson (2000) have reported that A VP significantly potentiates NE ~-adrenergic 
receptor action by increasing the induction of cAMP accumulation in hippocampal slices. 
This A VP-induced cAMP increase was found not to occw- in the absence of NE. 
Propranolol blocked both the NE-induced accumulation of cAMP and the cAMP 
enhancement effect of A VP. The adenylate cyclase activator, forskolin, was fOLmd to 
produce a 2-fold increase in cAMP accumulation, but there was no change in the 
presence of A VP. This provides evidence that A VP is not modulating adenylate cyclase 
directly, but suggests that it is likely a receptor-coupled event. Petit, Barveris and Jard 
(1988) examined A VP in the superior cervical ganglion and found that A VP potentiates 
cAMP accumulation when induced by the specific ~-agonist isoproterenol. Brinton and 
McEwen (1989) also found A VP-induced neuromodulation of cAMP in the dentate gyrus 
was a Ca2+-dependent process. The AVP-induced potentiation of cAMP was blocked by 
an antagonist to the Ca2+-binding protein, calmodulin. Interestingly, the AVP4-9 
fragment did not enhance cAMP, a point I will return to in considering the effects of 
DGAVP. 
If A VP and NE directly interact, the receptor systems may be functionally or 
structurally coupled in select regions within the hippocampus. Brinton (1998) examined 
this and found that high concentrations of A VP in postnatal animals resulted in a down-
regulation of NE-induced cAMP formation, but no change in vasopressin potentiation. 
They also fotmd that a site-specific upregulation of vasopressin receptors occurred 
following lesions to the dorsal noradrenergic bundle. This lesion also resulted in the 
upregulation of the vasopressin receptor system that modulates adrenergic stimulated 
adenylate cyclase (Brinton 1990; 1998). This presence of A VP receptors after a DNB 
lesion indicates that the A VP receptors may be postsynaptic to noradrenergic terminals. 
Such results suggest that vasopressin and adrenergic receptors are an adaptive and 
interactive complex. 
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In the dentate gyrus, the present experiment argues that electrophysiological 
A VP-induced potentiation in the dentate gyrus requires NE and ~-adrenoceptor 
activation. Studies by Stanton and Sarvey (1985a; 1985b; 1985c) also argue that high 
frequency-induced LTP depends on NE and ~-adrenoceptor activation in the dentate 
gyrus and that both frequency-induced LTP and NE-induced LTP initiate increases in 
cAMP ( Stanton and Sarvey, 1985b; 1985c ). L TP of the perforant path evoked potential in 
vitro could not be induced with NE depletion, but recovered after application of NE. 
Consistent with a requirement for cAMP, ~-adrenoceptor antagonists blocked L TP in the 
dentate gyrus (Stanton and Sarvey, 1985a; 1985c ). In vivo there is partial, but less 
complete, dependence of high frequency L TP effects, specifically potentiation of the 
EPSP slope, on ~-adrenoceptor activation in dentate gyrus (Munro et al , 2001 ). Thus, NE 
appears to be an important contributor to long-term enhancement of functional 
connectivity in the perforant path input to dentate gyrus. 
In an attempt to localize the site(s) where the interaction between NE and A VP 
may occur, Brinton (2000) found that there are multiple sites within the hippocampus 
including especially the rostral dendritic zone of the dentate gyrus and the hilar or 
polymorph region, as well as the CA3 subfield. In these areas there is a strong parallel 
between ~ 1 and A VP receptor distribution. Brinton (2000) also examined temporal 
properties of adrenergic and vasopressin receptor interactions and found that pre-
activation (for 1 minute) of the vasopressin V 1 receptor prior to NE activation of ~­
adrenergic receptors resulted in a significantly enhanced generation of cAMP. This 
synergy was found in both neurons and glia (Son and Brinton, 1998). This suggests that 
temporal priming by vasopressin may have a special role in the enhancement effect of 
NE-induced potentiation. Such a prediction remains to be tested in electrophysiological 
and/or behavioural experiments. Brinton and McEwen argued the properties of AVP-NE 
neuromodulation paralleled the associative learning requirements of spatial and temporal 
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coupling. The calcium dependency of A VP potentiation of cAMP is also in line with the 
calcitm1 dependency for induction of associative long-term potentiation (Brinton 1990). 
NE and A VP dissociation of slope and spike effects 
One explanation for the weak correlations between slope and spike effects, which 
are seen with in vivo E studies as well as described here for A VP, is the differential 
effect ofNE on the medial and lateral perforant path input to the dentate gyrus. 
NE modulation preferentially potentiates input from the medial perforant path in 
the middle molecular layer synapses of the dentate gyrus while depressing synaptic input 
from the lateral perforant path in the outer molecular layer (Dahl and Sarvey, 1989). The 
medial/lateral pathways not only terminate in different parts of the dentate gyrus 
molecular layer, but also arise from different pat1s of the entorhinal cortex: the medial 
and lateral cortices (Hjorth-Simonsen and Jeune, 1972). However the dentate gyrus and 
the CA3 receive projections from both medial and lateral entorhinal cortex and the two 
pathways show interactive effects (McNaughton and Barnes, 1977; Abraham and 
McNaughton, 1984). For example, when LTP is induced in one pathway, there IS a 
concurrent long-lasting depression (LTD) of responses evoked by activation of the other 
pathway (Abraham and Goddard, 1983). LTD entails a decrease in synaptic efficacy at 
potentiated synapses which is hypothesized to be necessary to prevent oversaturation of 
inputs and to increase the storage capacity of the hippocampus network (Doyere et al , 
1997). In the Dahl and Sarvey (1989) in vitro study, they reported that NE induces 
pathway specific potentiation and depression from stimulation of medial and lateral 
perforant paths respectively, as recorded in the dentate gyrus, which were both blocked 
by the ~-adrenergic antagonist, propranolol. The NE effect, then, is asymmetrical with 
only the medial pathway showing potentiation. It is the medial population spike that was 
investigated in these experiments as judged by latency, while the EPSP was a mixture of 
both medial and lateral components and might not be consistently potentiated depending 
on the relative ratio of the two synaptic inputs. 
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In companng A VP results to electrophysiological results reported for NE, 
typically, slope increases are seen more with NE in vitro. Lacaille and Harley (1985) 
reported in vitro that NE increased both amplitude and EPSP slope with 47% of the spike 
amplitude accounted for by the increase in EPSP slope. Another study (Stanton and 
Sarvey; 1987) examined dendritic EPSPs and found that NE resulted in increased 
dendritic EPSPs and increased population spike amplitude. The greater consistency of 
EPSP slope potentiation in vitro may relate to the easier isolation of the medial perforant 
path fibers in that preparation. 
It will be interesting to examine whether or not A VP potentiation effects show the 
san1e pathway selectivity as NE effects. Such a selectivity would be strongly predicted by 
the present findings and would argue that A VP and NE cause the network to process 
some inputs at the expense of others. Nonetheless, NE and the activation of ~­
adrenoceptors is reported to be essential for both medial and lateral perforant path high 
frequency L TP in the perforant pathway (Bramham et al, 1997) and A VP could also 
contribute to potentiation of both pathways. 
A recent finding shows that NE can induce a delayed EPSP slope potentiation that 
is not observable in the first 3 hours of recording in an awake rat (Walling and Harley, 
2004). Walling and Harley found infusion of glutamate into the LC produced an initial 
increase in population spike with no effect on EPSP slope. Potentiation was seen 24 
hours later in both the spike and EPSP slope. The ~-antagonist, propranolol and the 
protein synthesis inhibitor, anisomycin, blocked the long-term effects on EPSP slope and 
spike. In the Walling and Harley experiments slope completely accounted for spike 
increases 24 hours after NE release, but did not account for the initial spike increases. It 
will be of interest to examine A VP potentiation in awake rats to see if a similarly delayed 
slope potentiation occurs. 
To summarize Experiment 2, briefly, AVP potentiation of EPSP slope and 
population spike amplitude of perforant path input depends on ~-adrenoceptor activation. 
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The dissociation of slope and spike seen in the weak or absent correlative relationship 
suggests A VP effects in vivo are like NE effects in vivo. This dissociation may relate to 
s lective modulation of medial and lateral perforant path inputs or to distinct temporal 
and/or mechanistic modulations for the EPSP slope and spike components. 
A VP Fragment Effects: Experiment 3 
In the present study, the fragment DGAVP, a V1a receptor agonist, resulted in 
increases in population spike amplitude across all tlu·ee animals while showing varied and 
inconsistent effects on EPSP slope including decrease, increase and no change. This 
variable EPSP slope pattern is also reported with NE in vivo (Klukowski and Harley, 
1994; Harley et al , 1996; Walling and Harley, 2004) as well as in low dose in vitro 
isoproterenol studies (Dahl and Li , 1994). Population spike increases occur independently 
of slope increases when NE activation is increased in vivo, using a variety of NE release 
paradigms. 
While using the full A VP molecule produced both slope and spike changes, the 
pattern of effects argued for separate mechanisms. The spike, but not slope, potentiation 
produced by DGA VP strengthens the case for multiple mechanisms of A VP action. 
Metabolite fragments of A VP, such as DGAVP (Burbach et al. , 1983), show 
several differences from the parent molecule. Fragments bind preferentially to the 
polymorph region of the dentate gyrus, whereas the full molecule binds to the molecular 
layer as well (Brinton 1984; 1986; Du et al, 1994). The A VP4-9 fragment was reported 
not to synergistically elevate NE-induced cAMP in in vitro experiments (Brinton & 
McEwen,l994), although it is effective behaviourally. DGAVP, an AVP 4-8 fragment, 
was not tested in the cAMP study, although an earlier experiment reported DGAVP given 
intraperitoneally increased cAMP for up to 24 hours in several brain regions including 
hippocampus (Schneider et al , 1982). However the inverted U-shaped dose-response 
relationship for passive avoidance memory with A VP4-9 was not apparent for the A VP4-
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8 derivative (Burbach et al, 1983). In this early study pg quantities of A VP4-8 were 
effective at all doses tried. It will be of interest in future in vivo electrophysiological 
studies to try pg doses, but the lack of an inverted U curve in the earlier memory study 
suggests the pattern of spike potentiation would not be altered by lower doses. 
Since the spike potentiation induced by the parent molecule here was blocked by 
propranolol it is likely that cAMP is involved in spike potentiation, but an alternative 
mechanism could be a synergistic calcium action, which will be treated in more detail in 
a later section. NE itself influences both molecular layer and the polymorph interneuron 
region (Brown et al, 2005), so there could be two distinct spatial targets of modulation by 
A VP and its metabolites which would involve NE. 
As previously mentioned in the introduction, evidence derived from studies of 
DGA VP suggests that this peptide analog is virtually devoid of vasopressor effects, 
having little antidiuretic, corticotrophin-releasing activity, cardiovascular or endocrine 
effects (De Wied et al , 1972; Van Wimersma Greidanus et al , 1979). Administration of 
DGA VP has been found to result in resistance to extinction of active avoidance 
behaviour (De Wied and Bohus, 1966; Burbach et al, 1983; De Wied et al, 1984; Gaffori 
and De Wied, 1985). Such effects on extinction suggest that the peptide tends to work by 
strengthening previously learned responses. In these studies, they found that both A VP 
and DGAVP resulted in increased resistance, but DGAVP was more potent in facilitating 
passive avoidance behaviour. This supports the proposal that A VP promotes the activity 
in the dentate gyrus directly and not through pressor effects. Our experiments show that 
both A VP and DGA VP increased the perforant path evoked potential in the dentate gyrus 
with DGAVP causing increased cell excitability. DGAVP, like A VP, was also found to 
improve acquisition of an autoshaped behaviour thus demonstrating the specificity of the 
fragment for learning and memory processes (Messing and Sparber, 1983). 
De Wied and colleagues (1984) found that A VP produced a pressor effect and 
facilitated passive avoidance retention when administered peripherally while it only 
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resulted in enhanced passive avoidance response when centrally (icv) administered. A VP 
4-8, the more active DGA VP molecule, produced the facilitation in the passive avoidance 
retention when administered either centrally or peripherally. Thus it seems the receptors 
mediating the pressor effects are in the periphery and not in the brain. 
In the present study, the fragment molecule is working differently than in the first 
experiments such that it is more similar to the effects of in vivo NE (increased population 
spike amplitude and decreased or no change in the EPSP). Naturally, it is hard to draw a 
conclusion from the response of 3 subjects and so a larger study is needed for a more 
complete examination of specific vasopressin fragments. But if this outcome is an 
accurate reflection of DGA VP effects, then the larger vasopressin molecule appears to 
recruit more mechanisms then the specific targeted fragment. The larger molecule may 
interact more with other transmitters and pathways. It would be interesting to have done 
the double pipette study with the fragment and propranolol to assess the importance of~­
adrenoceptors in the fragment effect. . 
A VP and NE Release 
Vasopressin and NE appear to coexist m the rat LC (Caffe and 
colleagues, 1985; 1988). High concentrations of A VP have been found in the rat and the 
human LC (Jenkins et al, 1984; Hawthorn et al, 1984) which also contains A VP receptors 
(Phillips et al, 1988). In human brain, radioimmunoassay has shown that substantial 
amounts of vasopressin-like immunoreactivity are present in the LC (Rossor et al , 1980). 
Olpe and Baltzer (1981) found that micro iontophoretic administration of A VP or LVP 
excites noradrenergic neurons in the LC of the rat. This was also found in the LC of the 
cat (Andre and colleagues, 1992). Thus LC is a possible site for the interaction of 
vasopressin and NE containing neurons which indicates an additional site by which 
vasopressin could affect NE release when it is given intracerebroventricularly. A VP has 
been found to increase NE levels in the hypothalamus, hippocampus and tuberculum 
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olfactorium when given intraperitoneally (Szadowska et a!, 1982) and intraventricularly 
(Schwarzberg et a!, 1981 ). Since vasopressin-induced NE release has also been proposed 
via an intrahippocampal route, as mentioned in earlier papers (Metzger et al, 1994; 
Brinton et al , 2000), there may be several routes for synergy. 
In this study, A VP and DGA VP were infused into the lateral ventricles with the 
expectation that it would be distributed easily throughout the brain to the target neurons 
via diffusion within the CSF and the extracellular fluid . A disadvantage of this technique 
is the likelihood of interaction with targets other than the area of interest. As just 
described, the LC itself is likely to be one source of influence in the present study. Some 
studies promote the use of microdialysis techniques to avoid these extra interactional 
effects and to mimic more closely the natural release patterns in the brain (Engelmann et 
al, 1992; 1994; 1996). A microdialysis approach would be of interest for future studies 
looking at A VP modulation effects restricted to the dentate gyrus. 
Mechanisms of A VP Effects 
In addition to the ability of A VP to enhance the ~-adrenoceptor initiated rise in 
cAMP discussed above, A VP has important and independent actions on intracellular 
calcium modulation. Son and Brinton (2001) found that activation of the vasopressin V1 
receptor produced a rise in intracellular Ca2+ through the activation of the 
phosphotidyinositol signalling pathway and L-type Ca2+ channels. Fragments such as 
A VP 4-9 (Nakayama et al., 2000) also have this action. A VP thus causes intracellular 
Ca2+ concentration increases via release from intracellular Ca2+ stores and via influx from 
extracellular Ca2+ (Nakayama et al, 2000; Yibchok et al, 2000). The rise of the 
intracellular Ca2+ concentration results in increased Ca2+ -dependent neurotransmitter 
release (Son and Brinton, 1998) and NMDA-activated Ca2+ currents. This suggests that 
A VP actions on the IP3/intracellular Ca2+ concentration pathway in the rat hippocampus, 
might be important in enhancing the range of synaptic plasticity. A VP4-8 also stimulates 
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IP3 metabolism in the hippocampal slice in the presence of GTP (Gu and Du, 1991a). 
Studies have found that among the vasopressin analogs, A VP 4-8 was a hundred times 
higher in potency than the parent molecule A VP in facilitating the retention of passive 
avoidance learning ( Gaffori and De Wied, 1986; De Wied et al, 1991 ). 
However, A VP appears to require adrenergic innervation to the hippocampus to 
promote synaptic plasticity (as seen here with propranolol) and learning since lesions to 
the dorsal noradrenergic bundle abolished the behavioral effects of A VP (Kovacs et al, 
1979b ). Thus, if the calcium effects are relevant they must interact in some way with NE. 
NE itself promotes the opening of calcium L+ channels in the dentate gyrus granule cells 
(Gray and Johnston, 1987) and calcium effects of the two modulators may be additive or 
synergistic in promoting plasticity. This remains to be investigated directly. 
Another possible mechanism of the A VP effects on synaptic plasticity is A VP's 
activation of the receptor mediated signaling pathway involving mitogen-activated 
protein kinase (MAPK). This pathway is also recruited by NE (Chen et al , 2007). 
Administration of A VP 4-8 (sc) resulted in a significant increase of MAPK activity in the 
hippocampus after 2 hours, but the protein levels had not increased, indicating that the 
MAPK increase stimulated by AVP4-8 was caused by a short-term activation process 
through protein phosphorylation and not by protein expression (Qiao and Du, 1998). 
Trophic factors are also promoted by the 4-8 A VP fragment. Zhou et al ( 1995) 
found that nerve growth factor (NGF) mRNA expression in the hippocampus was 
significantly enhanced 12 hours after administration of A VP4-8 (sc). They concluded that 
the NGF gene was one of the target genes responsible for memory-enhancing responses 
induced by A VP4-8 and that the enhancement of NGF gene expression may be involved 
in the signaling pathway mediated by the A VP4-8 receptor. In a subsequent study by 
Zhou and colleagues (1996), memory impaired rats prepared by prenatal hypoxia showed 
that NGF expression increased from a low level to a normal level when given an AVP4-8 
agonist and the acquisition and maintenance of behavioural responses significantly 
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improved. Such studies confirm the role of both A VP4-8 and NGF in the learning and 
memory process. Zhou and colleagues (1997) then studied the in vivo expression of 
BDNF and neurotrophin 3 (NT3) genes as well as oxytocin and reported that only BDNF 
was significantly enhanced by A VP4-8 administration in the hippocan1pus. Although 
BDNF facilitates both short- and long-term memory, the increase of BDNF mRNA 
transcription 12 hours after A VP 4-8 indicates a long-term process. Whether any of the 
trophic factors could contribute to the synaptic plasticity and cell excitability changes 
seen here remains to be determined. They are more likely to play a role in late phases of 
plasticity than earlier ones such as those studied here. 
Vasopressin in real life 
Many of the behavioural studies on A VP have involved usmg an aversive 
situation for learning paradigm. Some studies have shown that AVP influences memory 
of emotional or stressful events, much like NE. Cahill's study (Cahill et al, 1994) 
suggested that memory is enhanced around stressful times or experiences because of a 
surge in NE. The participants are better able to recall a traumatic portion of a story or 
movie and this recall is diminished when participants are given beta blockers which block 
the effects of the NE surge. Some studies have reported that novelty of a stimulus or 
event and emotional stimuli are also associated with an A VP enhancement in processing 
(Naumann eta!, 1991 ; Pietrowski et al , 1996). In Naumrum et al (1991), subjects treated 
with A VP showed enhanced memory performance, but also showed a higher performance 
with emotional content as compared to neutral stimuli . A study by Ioder et al ( 1998) 
found that prolonged exercise, which serves as a form of stress, increases peripheral A VP 
in male athletes. NE is also increased with muscular stress at1d has been shown to 
enhance memory under those conditions (Neilson and Jensen, 1994; Neilson et a! , 1996). 
AVP may prime the information pathways under the satne circumstances as NE, the 
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release of which has been related to novel and emotional events as well as muscular 
stress. A VP may normally work with NE to enhance processing of significant stimuli. 
In a clinical vein one of my own interests is the neural basis of autism and 
recently A VP has been linked to this disorder. Autism or autism spectrum disorder is a 
neurological developmental disorder characterized by fundamental deficits in social 
behavior, social communication, language and cognitive development, excessive anxiety 
or hyperreactivity to stressful experiences and a tendency toward compulsive repetitive 
behavior. Such deficits vary in severity within the spectrum. Autism is also male biased 
afflicting males 4-5 times more than females (Chakrabarti and Fombonne, 2005 ; 
Fombonne, 2003). There is considerable evidence that autism is highly heritable and 
likely to be determined by genetic and polygenic mechanisms (Folstein et al, 2003). 
Given the complexity of the symptoms of autism, it is not unexpected that multiple sites 
of anatomical abnormalities have been hypothesized to underlie the different 
characteristics of this disorder. Abnormalities have been found throughout the brain 
including the cerebellum, amygdala, and the hippocampus (Bauman and Kemper, 1994; 
Courchesne, 1997; Kemper and Bauman, 1998; Courchesne et al , 1999; Nicolson et al , 
2006). There is growing evidence that an abnormality in A VP neurotransmission may 
account for certain features of autism ( Insel et al , 1999; Nelson et al , 2001; Jentsch et al , 
2003 ; Schuman eta! , 2004; Wassink et al , 2004; Emanuele 2006). 
Many studies implicating A VP ' s connection with autism involve the examination 
of the processing of social cues, social recognition or social memory which is thought to 
depend on septal AVP (Thor and Holloway, 1982; Dantzer et al, 1987; 1988; Popik et al , 
1992). Social memory tests are a relatively natural test of memory in rodents. The test of 
social memory originally proposed by Thor and Holloway (1982) was based on the fact 
that adult male rats spend a great amount of time investigating novel juveniles and less 
time investigating ones to which they have already been exposed. The rats exposed to the 
same juvenile 30 minutes after the initial exposure display less investigation behavior 
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which is interpreted as the adult forming a memory of the juvenile. But if the re-exposure 
occurs 2 hours later, the juvenile is not recognized and is thoroughly investigated which 
consists of sniffing, nosing, following and grooming. This form of memory is thought to 
be based on the olfactory characteristics of the juvenile conspecific. 
Centrally injected A VP (0.5 - 2.0 ng icv) has been found to facilitate social 
memory in rats. A VP given immediately after investigation of the juvenile resulted in 
decreased social investigation of the same juvenile at the long (120 minute) interexposure 
interval (Lemoal et al , 1987). Thus the memory of that particular juvenile lasted longer 
with the administration of AVP. Social memory studies with AVP have focused on the 
lateral septum as the crucial mediating structure, but it would be of interest to examine 
A VP effects in dentate gyrus on this memory as well. 
My own experience leads me to suggest an overactivity of the A VP system rather 
than a deficit as a possible abnormality in autism. Because of evidence for an inverted U 
curve function in the effects of A VP, even on cAMP activation, too much AVP could 
lead to abnormalities that would be characterized as 'overdrive' in some domains and 
'losses' in others depending on the dose-response relationship. While these ideas are 
highly speculative, the results of the present study lead me to suggest that treatment with 
propranolol might be useful in reducing some autistic symptomalogy. Such treatment has 
been tried successfully with anxiety disorders and post-traumatic stress disorders (Pitman 
eta!, 2002; Raskind et al , 2007; Strawn et al , 2007). 
Conclusion 
A VP potentiates perforant path-induced EPSP slope and population spike 
amphtude and this potentiation appears to be long-lasting. Potentiation of the two 
components are dissociable suggesting distinct mechanisms. The abi lity of a P-adrenergic 
antagonist in the dentate gyrus to prevent both EPSP slope and population spike 
potentiation argues that these effects are mediated via a synergistic interaction with P-
adrenoceptor activation by NE. A critical dependence of A VP promotion of learning and 
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memory in the dentate gyrus on NE has previously been demonstrated (Kovacs et al , 
1979). 
The present results provide a model for the way in which A VP might promote 
memory through the promotion of synaptic plasticity and cell excitability to 
glutamatergic inputs. The pharmacological block of that plasticity by blocking the post-
synaptic effects of NE provides a clear counterpart to the dependence of memory 
enhancement on the presence of NE fibers shown earlier (Metzger et al , 1994; Alescio-
Lautier and Soumireu-Morat,1998). Surprisingly, a behaviourally highly effective 
metabolite of A VP, DGA VP only produced long-lasting increases in cell excitability. 
This further supports the dissociation of the two plasticity mechanisms seen with A VP 
and provides a tool for their dissection in future studies. The possibility that cell 
excitability increases are another component of associative learning changes deserves 
further investigation. 
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